TW202311205A - Compound, curable composition, and cured product - Google Patents
Compound, curable composition, and cured product Download PDFInfo
- Publication number
- TW202311205A TW202311205A TW111115598A TW111115598A TW202311205A TW 202311205 A TW202311205 A TW 202311205A TW 111115598 A TW111115598 A TW 111115598A TW 111115598 A TW111115598 A TW 111115598A TW 202311205 A TW202311205 A TW 202311205A
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- compound
- curable composition
- carbon atoms
- bond
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 197
- 239000000203 mixture Substances 0.000 title claims description 103
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 77
- 125000000524 functional group Chemical group 0.000 claims abstract description 74
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 45
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 26
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims abstract description 14
- 125000005843 halogen group Chemical group 0.000 claims abstract description 13
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 12
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 12
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 8
- -1 acryl Chemical group 0.000 claims description 144
- 239000000463 material Substances 0.000 claims description 48
- 239000003795 chemical substances by application Substances 0.000 claims description 43
- 239000011248 coating agent Substances 0.000 claims description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 25
- 239000003505 polymerization initiator Substances 0.000 claims description 21
- 125000003700 epoxy group Chemical group 0.000 claims description 15
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 14
- 150000003553 thiiranes Chemical group 0.000 claims description 13
- 239000000853 adhesive Substances 0.000 claims description 12
- 230000001070 adhesive effect Effects 0.000 claims description 12
- 239000012948 isocyanate Substances 0.000 claims description 12
- 125000005641 methacryl group Chemical group 0.000 claims description 12
- 239000003973 paint Substances 0.000 claims description 12
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 11
- 229920002554 vinyl polymer Polymers 0.000 claims description 11
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 10
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 238000010538 cationic polymerization reaction Methods 0.000 claims description 8
- 239000007870 radical polymerization initiator Substances 0.000 claims description 8
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 7
- 150000001412 amines Chemical class 0.000 claims description 7
- 150000001244 carboxylic acid anhydrides Chemical group 0.000 claims description 7
- 239000004848 polyfunctional curative Substances 0.000 claims description 7
- 125000001072 heteroaryl group Chemical group 0.000 claims description 6
- 150000002513 isocyanates Chemical class 0.000 claims description 6
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 6
- 150000002989 phenols Chemical class 0.000 claims description 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims description 5
- 125000003368 amide group Chemical group 0.000 claims description 4
- 150000002460 imidazoles Chemical class 0.000 claims description 4
- 239000004849 latent hardener Substances 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 2
- 239000000178 monomer Substances 0.000 description 47
- 239000004593 Epoxy Substances 0.000 description 32
- 239000000047 product Substances 0.000 description 29
- 239000002904 solvent Substances 0.000 description 29
- 150000002430 hydrocarbons Chemical group 0.000 description 25
- 238000000034 method Methods 0.000 description 21
- 238000006243 chemical reaction Methods 0.000 description 20
- 239000003822 epoxy resin Substances 0.000 description 20
- 229920000647 polyepoxide Polymers 0.000 description 20
- 230000000694 effects Effects 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000000576 coating method Methods 0.000 description 15
- 239000010408 film Substances 0.000 description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 12
- 238000010438 heat treatment Methods 0.000 description 10
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 150000003839 salts Chemical class 0.000 description 9
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 150000001334 alicyclic compounds Chemical class 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 125000002723 alicyclic group Chemical group 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- 238000000465 moulding Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 6
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 6
- 230000002411 adverse Effects 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 125000004429 atom Chemical group 0.000 description 5
- 238000000921 elemental analysis Methods 0.000 description 5
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 229940085991 phosphate ion Drugs 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- 125000001931 aliphatic group Chemical group 0.000 description 4
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 229910052799 carbon Inorganic materials 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000013078 crystal Substances 0.000 description 4
- 230000001186 cumulative effect Effects 0.000 description 4
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000004210 ether based solvent Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
- 150000007517 lewis acids Chemical class 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 4
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- 230000000704 physical effect Effects 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 238000006116 polymerization reaction Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- LWNGJAHMBMVCJR-UHFFFAOYSA-N (2,3,4,5,6-pentafluorophenoxy)boronic acid Chemical compound OB(O)OC1=C(F)C(F)=C(F)C(F)=C1F LWNGJAHMBMVCJR-UHFFFAOYSA-N 0.000 description 3
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 125000003277 amino group Chemical group 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 3
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 239000003094 microcapsule Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 239000003444 phase transfer catalyst Substances 0.000 description 3
- 229920006295 polythiol Polymers 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000001632 sodium acetate Substances 0.000 description 3
- 235000017281 sodium acetate Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- CUJPFPXNDSIBPG-UHFFFAOYSA-N 1,3-propanediyl Chemical group [CH2]C[CH2] CUJPFPXNDSIBPG-UHFFFAOYSA-N 0.000 description 2
- HECLRDQVFMWTQS-RGOKHQFPSA-N 1755-01-7 Chemical compound C1[C@H]2[C@@H]3CC=C[C@@H]3[C@@H]1C=C2 HECLRDQVFMWTQS-RGOKHQFPSA-N 0.000 description 2
- JAHNSTQSQJOJLO-UHFFFAOYSA-N 2-(3-fluorophenyl)-1h-imidazole Chemical compound FC1=CC=CC(C=2NC=CN=2)=C1 JAHNSTQSQJOJLO-UHFFFAOYSA-N 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 2
- KUAUJXBLDYVELT-UHFFFAOYSA-N 2-[[2,2-dimethyl-3-(oxiran-2-ylmethoxy)propoxy]methyl]oxirane Chemical compound C1OC1COCC(C)(C)COCC1CO1 KUAUJXBLDYVELT-UHFFFAOYSA-N 0.000 description 2
- RSEBUVRVKCANEP-UHFFFAOYSA-N 2-pyrroline Chemical compound C1CC=CN1 RSEBUVRVKCANEP-UHFFFAOYSA-N 0.000 description 2
- ULKLGIFJWFIQFF-UHFFFAOYSA-N 5K8XI641G3 Chemical compound CCC1=NC=C(C)N1 ULKLGIFJWFIQFF-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 2
- 239000002841 Lewis acid Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000006096 absorbing agent Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- 150000001335 aliphatic alkanes Chemical class 0.000 description 2
- JFCQEDHGNNZCLN-UHFFFAOYSA-N anhydrous glutaric acid Natural products OC(=O)CCCC(O)=O JFCQEDHGNNZCLN-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 239000004566 building material Substances 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- HDFRDWFLWVCOGP-UHFFFAOYSA-N carbonothioic O,S-acid Chemical class OC(S)=O HDFRDWFLWVCOGP-UHFFFAOYSA-N 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000013039 cover film Substances 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 150000001991 dicarboxylic acids Chemical class 0.000 description 2
- 238000007607 die coating method Methods 0.000 description 2
- 238000007606 doctor blade method Methods 0.000 description 2
- 239000003759 ester based solvent Substances 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 2
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 2
- CBFCDTFDPHXCNY-UHFFFAOYSA-N icosane Chemical compound CCCCCCCCCCCCCCCCCCCC CBFCDTFDPHXCNY-UHFFFAOYSA-N 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000001678 irradiating effect Effects 0.000 description 2
- NNPPMTNAJDCUHE-UHFFFAOYSA-N isobutane Chemical compound CC(C)C NNPPMTNAJDCUHE-UHFFFAOYSA-N 0.000 description 2
- 239000005453 ketone based solvent Substances 0.000 description 2
- 239000002649 leather substitute Substances 0.000 description 2
- 239000011968 lewis acid catalyst Substances 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- LVHBHZANLOWSRM-UHFFFAOYSA-N methylenebutanedioic acid Natural products OC(=O)CC(=C)C(O)=O LVHBHZANLOWSRM-UHFFFAOYSA-N 0.000 description 2
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- ZYURHZPYMFLWSH-UHFFFAOYSA-N octacosane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCC ZYURHZPYMFLWSH-UHFFFAOYSA-N 0.000 description 2
- WRKCIHRWQZQBOL-UHFFFAOYSA-N octyl dihydrogen phosphate Chemical compound CCCCCCCCOP(O)(O)=O WRKCIHRWQZQBOL-UHFFFAOYSA-N 0.000 description 2
- 125000000962 organic group Chemical group 0.000 description 2
- YCOZIPAWZNQLMR-UHFFFAOYSA-N pentadecane Chemical compound CCCCCCCCCCCCCCC YCOZIPAWZNQLMR-UHFFFAOYSA-N 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229930195734 saturated hydrocarbon Natural products 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical compound O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- 238000010345 tape casting Methods 0.000 description 2
- BGHCVCJVXZWKCC-UHFFFAOYSA-N tetradecane Chemical compound CCCCCCCCCCCCCC BGHCVCJVXZWKCC-UHFFFAOYSA-N 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- IIYFAKIEWZDVMP-UHFFFAOYSA-N tridecane Chemical compound CCCCCCCCCCCCC IIYFAKIEWZDVMP-UHFFFAOYSA-N 0.000 description 2
- RSJKGSCJYJTIGS-UHFFFAOYSA-N undecane Chemical compound CCCCCCCCCCC RSJKGSCJYJTIGS-UHFFFAOYSA-N 0.000 description 2
- JOYRKODLDBILNP-UHFFFAOYSA-N urethane group Chemical group NC(=O)OCC JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- UUIPAJHTKDSSOK-UHFFFAOYSA-N (2-nonylphenyl) dihydrogen phosphate Chemical compound CCCCCCCCCC1=CC=CC=C1OP(O)(O)=O UUIPAJHTKDSSOK-UHFFFAOYSA-N 0.000 description 1
- KQQSTPXKXXMWOJ-UHFFFAOYSA-N (3,5-difluoro-4-methoxyphenoxy)boronic acid Chemical compound FC=1C=C(C=C(C=1OC)F)OB(O)O KQQSTPXKXXMWOJ-UHFFFAOYSA-N 0.000 description 1
- 239000001124 (E)-prop-1-ene-1,2,3-tricarboxylic acid Substances 0.000 description 1
- WIWAMLWMBGHJLF-BTJKTKAUSA-N (z)-but-2-enedioic acid;2-hydroxyethyl 2-methylprop-2-enoate Chemical compound OC(=O)\C=C/C(O)=O.CC(=C)C(=O)OCCO WIWAMLWMBGHJLF-BTJKTKAUSA-N 0.000 description 1
- DKFDEXZGNOUTHT-BTJKTKAUSA-N (z)-but-2-enedioic acid;2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C.OC(=O)\C=C/C(O)=O DKFDEXZGNOUTHT-BTJKTKAUSA-N 0.000 description 1
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- 125000004502 1,2,3-oxadiazolyl group Chemical group 0.000 description 1
- 125000004511 1,2,3-thiadiazolyl group Chemical group 0.000 description 1
- 125000001359 1,2,3-triazol-4-yl group Chemical group [H]N1N=NC([*])=C1[H] 0.000 description 1
- 125000001506 1,2,3-triazol-5-yl group Chemical group [H]N1N=NC([H])=C1[*] 0.000 description 1
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000001414 1,2,4-triazol-5-yl group Chemical group [H]N1N=C([H])N=C1[*] 0.000 description 1
- 125000004506 1,2,5-oxadiazolyl group Chemical group 0.000 description 1
- 125000004517 1,2,5-thiadiazolyl group Chemical group 0.000 description 1
- 125000001781 1,3,4-oxadiazolyl group Chemical group 0.000 description 1
- 125000004520 1,3,4-thiadiazolyl group Chemical group 0.000 description 1
- IFPMZBBHBZQTOV-UHFFFAOYSA-N 1,3,5-trinitro-2-(2,4,6-trinitrophenyl)-4-[2,4,6-trinitro-3-(2,4,6-trinitrophenyl)phenyl]benzene Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C(C=2C(=C(C=3C(=CC(=CC=3[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)C(=CC=2[N+]([O-])=O)[N+]([O-])=O)[N+]([O-])=O)=C1[N+]([O-])=O IFPMZBBHBZQTOV-UHFFFAOYSA-N 0.000 description 1
- KATAXDCYPGGJNJ-UHFFFAOYSA-N 1,3-bis(oxiran-2-ylmethoxy)propan-2-ol Chemical compound C1OC1COCC(O)COCC1CO1 KATAXDCYPGGJNJ-UHFFFAOYSA-N 0.000 description 1
- OMIVCRYZSXDGAB-UHFFFAOYSA-N 1,4-butanediyl Chemical group [CH2]CC[CH2] OMIVCRYZSXDGAB-UHFFFAOYSA-N 0.000 description 1
- ALQLPWJFHRMHIU-UHFFFAOYSA-N 1,4-diisocyanatobenzene Chemical compound O=C=NC1=CC=C(N=C=O)C=C1 ALQLPWJFHRMHIU-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- IVMHNKJWTRJTRU-UHFFFAOYSA-N 1-isocyanato-2-methoxyethane Chemical compound COCCN=C=O IVMHNKJWTRJTRU-UHFFFAOYSA-N 0.000 description 1
- RTBFRGCFXZNCOE-UHFFFAOYSA-N 1-methylsulfonylpiperidin-4-one Chemical compound CS(=O)(=O)N1CCC(=O)CC1 RTBFRGCFXZNCOE-UHFFFAOYSA-N 0.000 description 1
- RNFJDJUURJAICM-UHFFFAOYSA-N 2,2,4,4,6,6-hexaphenoxy-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene Chemical compound N=1P(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP(OC=2C=CC=CC=2)(OC=2C=CC=CC=2)=NP=1(OC=1C=CC=CC=1)OC1=CC=CC=C1 RNFJDJUURJAICM-UHFFFAOYSA-N 0.000 description 1
- AZUHIVLOSAPWDM-UHFFFAOYSA-N 2-(1h-imidazol-2-yl)-1h-imidazole Chemical compound C1=CNC(C=2NC=CN=2)=N1 AZUHIVLOSAPWDM-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- VVHFXJOCUKBZFS-UHFFFAOYSA-N 2-(chloromethyl)-2-methyloxirane Chemical compound ClCC1(C)CO1 VVHFXJOCUKBZFS-UHFFFAOYSA-N 0.000 description 1
- VMSIYTPWZLSMOH-UHFFFAOYSA-N 2-(dodecoxymethyl)oxirane Chemical compound CCCCCCCCCCCCOCC1CO1 VMSIYTPWZLSMOH-UHFFFAOYSA-N 0.000 description 1
- BXGYYDRIMBPOMN-UHFFFAOYSA-N 2-(hydroxymethoxy)ethoxymethanol Chemical compound OCOCCOCO BXGYYDRIMBPOMN-UHFFFAOYSA-N 0.000 description 1
- BEWCNXNIQCLWHP-UHFFFAOYSA-N 2-(tert-butylamino)ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCNC(C)(C)C BEWCNXNIQCLWHP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- VSRMIIBCXRHPCC-UHFFFAOYSA-N 2-[2-[2-[2-[2-(oxiran-2-ylmethoxy)ethoxy]ethoxy]ethoxy]ethoxymethyl]oxirane Chemical compound C1OC1COCCOCCOCCOCCOCC1CO1 VSRMIIBCXRHPCC-UHFFFAOYSA-N 0.000 description 1
- NREFJJBCYMZUEK-UHFFFAOYSA-N 2-[2-[4-[2-[4-[2-[2-(2-methylprop-2-enoyloxy)ethoxy]ethoxy]phenyl]propan-2-yl]phenoxy]ethoxy]ethyl 2-methylprop-2-enoate Chemical compound C1=CC(OCCOCCOC(=O)C(=C)C)=CC=C1C(C)(C)C1=CC=C(OCCOCCOC(=O)C(C)=C)C=C1 NREFJJBCYMZUEK-UHFFFAOYSA-N 0.000 description 1
- GSLTVFIVJMCNBH-UHFFFAOYSA-N 2-isocyanatopropane Chemical compound CC(C)N=C=O GSLTVFIVJMCNBH-UHFFFAOYSA-N 0.000 description 1
- ZQNVWAQNCHHONO-UHFFFAOYSA-N 2-methyl-1-phenylimidazole Chemical compound CC1=NC=CN1C1=CC=CC=C1 ZQNVWAQNCHHONO-UHFFFAOYSA-N 0.000 description 1
- 125000003229 2-methylhexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 2-phenyl-1h-imidazole Chemical compound C1=CNC(C=2C=CC=CC=2)=N1 ZCUJYXPAKHMBAZ-UHFFFAOYSA-N 0.000 description 1
- BKCCAYLNRIRKDJ-UHFFFAOYSA-N 2-phenyl-4,5-dihydro-1h-imidazole Chemical compound N1CCN=C1C1=CC=CC=C1 BKCCAYLNRIRKDJ-UHFFFAOYSA-N 0.000 description 1
- LLEASVZEQBICSN-UHFFFAOYSA-N 2-undecyl-1h-imidazole Chemical compound CCCCCCCCCCCC1=NC=CN1 LLEASVZEQBICSN-UHFFFAOYSA-N 0.000 description 1
- UIDDPPKZYZTEGS-UHFFFAOYSA-N 3-(2-ethyl-4-methylimidazol-1-yl)propanenitrile Chemical compound CCC1=NC(C)=CN1CCC#N UIDDPPKZYZTEGS-UHFFFAOYSA-N 0.000 description 1
- GNSFRPWPOGYVLO-UHFFFAOYSA-N 3-hydroxypropyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCCO GNSFRPWPOGYVLO-UHFFFAOYSA-N 0.000 description 1
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 1
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- PMPVIKIVABFJJI-UHFFFAOYSA-N Cyclobutane Chemical compound C1CCC1 PMPVIKIVABFJJI-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- LVZWSLJZHVFIQJ-UHFFFAOYSA-N Cyclopropane Chemical compound C1CC1 LVZWSLJZHVFIQJ-UHFFFAOYSA-N 0.000 description 1
- MQJKPEGWNLWLTK-UHFFFAOYSA-N Dapsone Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=C1 MQJKPEGWNLWLTK-UHFFFAOYSA-N 0.000 description 1
- OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 239000004831 Hot glue Substances 0.000 description 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical group NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 1
- 239000005058 Isophorone diisocyanate Substances 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 229920000877 Melamine resin Polymers 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 1
- NQHAZTDQFIYTQD-UHFFFAOYSA-N SOS Chemical class SOS NQHAZTDQFIYTQD-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical group [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical class CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- FYYIUODUDSPAJQ-XVBQNVSMSA-N [(1S,6R)-7-oxabicyclo[4.1.0]heptan-3-yl]methyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCC1CC[C@H]2O[C@H]2C1 FYYIUODUDSPAJQ-XVBQNVSMSA-N 0.000 description 1
- 229940091181 aconitic acid Drugs 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052787 antimony Inorganic materials 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 239000013556 antirust agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000003849 aromatic solvent Substances 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000007611 bar coating method Methods 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- JYZIHLWOWKMNNX-UHFFFAOYSA-N benzimidazole Chemical compound C1=C[CH]C2=NC=NC2=C1 JYZIHLWOWKMNNX-UHFFFAOYSA-N 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- IDSLNGDJQFVDPQ-UHFFFAOYSA-N bis(7-oxabicyclo[4.1.0]heptan-4-yl) hexanedioate Chemical compound C1CC2OC2CC1OC(=O)CCCCC(=O)OC1CC2OC2CC1 IDSLNGDJQFVDPQ-UHFFFAOYSA-N 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 229940063013 borate ion Drugs 0.000 description 1
- 229940006460 bromide ion Drugs 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001721 carbon Chemical group 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- UETQVDZZPKAQIC-UHFFFAOYSA-N chlorane Chemical compound Cl.Cl.Cl.Cl UETQVDZZPKAQIC-UHFFFAOYSA-N 0.000 description 1
- XENVCRGQTABGKY-ZHACJKMWSA-N chlorohydrin Chemical compound CC#CC#CC#CC#C\C=C\C(Cl)CO XENVCRGQTABGKY-ZHACJKMWSA-N 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- GTZCVFVGUGFEME-IWQZZHSRSA-N cis-aconitic acid Chemical compound OC(=O)C\C(C(O)=O)=C\C(O)=O GTZCVFVGUGFEME-IWQZZHSRSA-N 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 239000004035 construction material Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 238000007766 curtain coating Methods 0.000 description 1
- LMGZGXSXHCMSAA-UHFFFAOYSA-N cyclodecane Chemical compound C1CCCCCCCCC1 LMGZGXSXHCMSAA-UHFFFAOYSA-N 0.000 description 1
- ZWAJLVLEBYIOTI-UHFFFAOYSA-N cyclohexene oxide Chemical group C1CCCC2OC21 ZWAJLVLEBYIOTI-UHFFFAOYSA-N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- WJTCGQSWYFHTAC-UHFFFAOYSA-N cyclooctane Chemical compound C1CCCCCCC1 WJTCGQSWYFHTAC-UHFFFAOYSA-N 0.000 description 1
- 239000004914 cyclooctane Substances 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- KYTNZWVKKKJXFS-UHFFFAOYSA-N cycloundecane Chemical compound C1CCCCCCCCCC1 KYTNZWVKKKJXFS-UHFFFAOYSA-N 0.000 description 1
- DIOQZVSQGTUSAI-NJFSPNSNSA-N decane Chemical compound CCCCCCCCC[14CH3] DIOQZVSQGTUSAI-NJFSPNSNSA-N 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000002542 deteriorative effect Effects 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical compound NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 description 1
- GYZLOYUZLJXAJU-UHFFFAOYSA-N diglycidyl ether Chemical compound C1OC1COCC1CO1 GYZLOYUZLJXAJU-UHFFFAOYSA-N 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- PXJJSXABGXMUSU-UHFFFAOYSA-N disulfur dichloride Chemical compound ClSSCl PXJJSXABGXMUSU-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010292 electrical insulation Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000007720 emulsion polymerization reaction Methods 0.000 description 1
- GKIPXFAANLTWBM-UHFFFAOYSA-N epibromohydrin Chemical compound BrCC1CO1 GKIPXFAANLTWBM-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- BGCNBOFPABQGNG-UHFFFAOYSA-N ethyl 2-(dimethylamino)acetate Chemical compound CCOC(=O)CN(C)C BGCNBOFPABQGNG-UHFFFAOYSA-N 0.000 description 1
- PVBRSNZAOAJRKO-UHFFFAOYSA-N ethyl 2-sulfanylacetate Chemical compound CCOC(=O)CS PVBRSNZAOAJRKO-UHFFFAOYSA-N 0.000 description 1
- RUJPPJYDHHAEEK-UHFFFAOYSA-N ethyl piperidine-4-carboxylate Chemical compound CCOC(=O)C1CCNCC1 RUJPPJYDHHAEEK-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000003063 flame retardant Substances 0.000 description 1
- 238000007775 flexo coating Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 238000007756 gravure coating Methods 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- LNCPIMCVTKXXOY-UHFFFAOYSA-N hexyl 2-methylprop-2-enoate Chemical compound CCCCCCOC(=O)C(C)=C LNCPIMCVTKXXOY-UHFFFAOYSA-N 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002429 hydrazines Chemical class 0.000 description 1
- 150000002483 hydrogen compounds Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 150000003949 imides Chemical group 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910001412 inorganic anion Inorganic materials 0.000 description 1
- 239000011810 insulating material Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000009878 intermolecular interaction Effects 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-M iodide Chemical compound [I-] XMBWDFGMSWQBCA-UHFFFAOYSA-M 0.000 description 1
- 229940006461 iodide ion Drugs 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000001282 iso-butane Substances 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- YDNLNVZZTACNJX-UHFFFAOYSA-N isocyanatomethylbenzene Chemical compound O=C=NCC1=CC=CC=C1 YDNLNVZZTACNJX-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- NIMLQBUJDJZYEJ-UHFFFAOYSA-N isophorone diisocyanate Chemical compound CC1(C)CC(N=C=O)CC(C)(CN=C=O)C1 NIMLQBUJDJZYEJ-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 125000001793 isothiazol-3-yl group Chemical group [H]C1=C([H])C(*)=NS1 0.000 description 1
- 125000004500 isothiazol-4-yl group Chemical group S1N=CC(=C1)* 0.000 description 1
- 125000004501 isothiazol-5-yl group Chemical group S1N=CC=C1* 0.000 description 1
- 125000001786 isothiazolyl group Chemical group 0.000 description 1
- 125000004284 isoxazol-3-yl group Chemical group [H]C1=C([H])C(*)=NO1 0.000 description 1
- 125000004498 isoxazol-4-yl group Chemical group O1N=CC(=C1)* 0.000 description 1
- 125000004499 isoxazol-5-yl group Chemical group O1N=CC=C1* 0.000 description 1
- 239000005340 laminated glass Substances 0.000 description 1
- 239000004611 light stabiliser Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JDSHMPZPIAZGSV-UHFFFAOYSA-N melamine Chemical compound NC1=NC(N)=NC(N)=N1 JDSHMPZPIAZGSV-UHFFFAOYSA-N 0.000 description 1
- 229910001507 metal halide Inorganic materials 0.000 description 1
- 150000005309 metal halides Chemical class 0.000 description 1
- NYEHYTMDKFXJEE-UHFFFAOYSA-N methyl 2-(ethylamino)acetate Chemical compound CCNCC(=O)OC NYEHYTMDKFXJEE-UHFFFAOYSA-N 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 125000001802 myricyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- HNHVTXYLRVGMHD-UHFFFAOYSA-N n-butyl isocyanate Chemical compound CCCCN=C=O HNHVTXYLRVGMHD-UHFFFAOYSA-N 0.000 description 1
- DIOQZVSQGTUSAI-UHFFFAOYSA-N n-butylhexane Natural products CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 1
- ZCYXXKJEDCHMGH-UHFFFAOYSA-N nonane Chemical compound CCCC[CH]CCCC ZCYXXKJEDCHMGH-UHFFFAOYSA-N 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMRZSTCPUPJPOJ-KNVOCYPGSA-N norbornane Chemical compound C1C[C@H]2CC[C@@H]1C2 UMRZSTCPUPJPOJ-KNVOCYPGSA-N 0.000 description 1
- BKIMMITUMNQMOS-UHFFFAOYSA-N normal nonane Natural products CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 1
- UHGIMQLJWRAPLT-UHFFFAOYSA-N octadecyl dihydrogen phosphate Chemical compound CCCCCCCCCCCCCCCCCCOP(O)(O)=O UHGIMQLJWRAPLT-UHFFFAOYSA-N 0.000 description 1
- OXUCOTSGWGNWGC-UHFFFAOYSA-N octane Chemical compound CCCCCCC[CH2-] OXUCOTSGWGNWGC-UHFFFAOYSA-N 0.000 description 1
- 239000012788 optical film Substances 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 125000003145 oxazol-4-yl group Chemical group O1C=NC(=C1)* 0.000 description 1
- 125000004304 oxazol-5-yl group Chemical group O1C=NC=C1* 0.000 description 1
- 125000000466 oxiranyl group Chemical group 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 description 1
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Chemical compound [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- 239000005011 phenolic resin Substances 0.000 description 1
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- XKJCHHZQLQNZHY-UHFFFAOYSA-N phthalimide Chemical compound C1=CC=C2C(=O)NC(=O)C2=C1 XKJCHHZQLQNZHY-UHFFFAOYSA-N 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 239000002685 polymerization catalyst Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000000168 pyrrolyl group Chemical group 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 239000003566 sealing material Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 125000003748 selenium group Chemical group *[Se]* 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000007784 solid electrolyte Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 125000003003 spiro group Chemical group 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 229960002317 succinimide Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- FWMUJAIKEJWSSY-UHFFFAOYSA-N sulfur dichloride Chemical compound ClSCl FWMUJAIKEJWSSY-UHFFFAOYSA-N 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010557 suspension polymerization reaction Methods 0.000 description 1
- 229910052714 tellurium Inorganic materials 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- 239000013008 thixotropic agent Substances 0.000 description 1
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 1
- RUELTTOHQODFPA-UHFFFAOYSA-N toluene 2,6-diisocyanate Chemical compound CC1=C(N=C=O)C=CC=C1N=C=O RUELTTOHQODFPA-UHFFFAOYSA-N 0.000 description 1
- GTZCVFVGUGFEME-UHFFFAOYSA-N trans-aconitic acid Natural products OC(=O)CC(C(O)=O)=CC(O)=O GTZCVFVGUGFEME-UHFFFAOYSA-N 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229950001577 trimetozine Drugs 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 238000004078 waterproofing Methods 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/18—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by etherified hydroxyl radicals
- C07D303/20—Ethers with hydroxy compounds containing no oxirane rings
- C07D303/22—Ethers with hydroxy compounds containing no oxirane rings with monohydroxy compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/87—Benzo [c] furans; Hydrogenated benzo [c] furans
- C07D307/89—Benzo [c] furans; Hydrogenated benzo [c] furans with two oxygen atoms directly attached in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D331/00—Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom
- C07D331/02—Three-membered rings
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/38—Esters containing sulfur
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G59/00—Polycondensates containing more than one epoxy group per molecule; Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups
- C08G59/18—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing
- C08G59/20—Macromolecules obtained by polymerising compounds containing more than one epoxy group per molecule using curing agents or catalysts which react with the epoxy groups ; e.g. general methods of curing characterised by the epoxy compounds used
- C08G59/22—Di-epoxy compounds
- C08G59/30—Di-epoxy compounds containing atoms other than carbon, hydrogen, oxygen and nitrogen
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D201/00—Coating compositions based on unspecified macromolecular compounds
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D7/00—Features of coating compositions, not provided for in group C09D5/00; Processes for incorporating ingredients in coating compositions
- C09D7/40—Additives
- C09D7/60—Additives non-macromolecular
- C09D7/63—Additives non-macromolecular organic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
- C09J11/02—Non-macromolecular additives
- C09J11/06—Non-macromolecular additives organic
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J201/00—Adhesives based on unspecified macromolecular compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Wood Science & Technology (AREA)
- Epoxy Resins (AREA)
- Epoxy Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
本發明係關於具有特定構造之化合物、包含該化合物之硬化性組成物及使該硬化性組成物硬化而成之硬化物。該硬化性組成物係能使用於自我修復材料、表面塗覆劑、塗料、接著劑或電池用材料之用途。The present invention relates to a compound having a specific structure, a curable composition containing the compound, and a cured product obtained by curing the curable composition. The curable composition can be used for self-healing materials, surface coating agents, paints, adhesives, or materials for batteries.
高分子材料雖係基於強固共價鍵而展現高力學性強度或高耐久性,但缺乏再加工性或再利用性,故難以修復擦傷或斷裂,尤其難以自我修復。作為耐久性或再加工性優異且修復容易之能自我修復性材料,已知有基於主體-客體相互作用般之分子間相互作用之方式(參照例如專利文獻1及2),或活用鍵結於高分子交聯構造上之懸鏈的自我修復材料(參照例如專利文獻3)、在樹脂材料等之基質中摻合封入能聚合之單體或觸媒之微膠囊等,在伴隨微膠囊等損壞之基質損傷時,會被新的單體成分填補並進行聚合,從而使基質機能回復的技術(參照例如專利文獻4及5)。但,專利文獻1~3之方法在製造材料時必須要有複雜的步驟,專利文獻4及5之方法則有由於微膠囊之摻合量等而自我修復次數受到限制等之問題。又,近年來為了解決該等問題,已知有對於使用動態共價鍵之材料施加外部刺激,而利用可逆性鍵結解離-再鍵結的自我修復材料(參照例如,專利文獻6及非專利文獻1)。 [先前技術文獻] [專利文獻] Although polymer materials exhibit high mechanical strength or high durability based on strong covalent bonds, they lack reworkability or reusability, so it is difficult to repair scratches or fractures, especially difficult to self-repair. As a self-healing material that is excellent in durability or reworkability and is easy to repair, there are known methods based on intermolecular interactions such as host-guest interactions (see, for example, Patent Documents 1 and 2), or by using bonds in Self-healing materials with catenary chains on the cross-linked polymer structure (see, for example, Patent Document 3), microcapsules in which polymerizable monomers or catalysts are mixed into a matrix of resin materials, etc., are accompanied by damage to the microcapsules, etc. When the matrix is damaged, it will be replaced by new monomer components and polymerized, thereby restoring the function of the matrix (see, for example, Patent Documents 4 and 5). However, the methods of Patent Documents 1 to 3 require complicated steps in the production of materials, and the methods of Patent Documents 4 and 5 have the problem that the number of times of self-repair is limited due to the amount of microcapsules blended. Also, in order to solve these problems in recent years, a self-healing material using reversible bond dissociation-rebonding is known by applying an external stimulus to a material using a dynamic covalent bond (see, for example, Patent Document 6 and Non-Patent Document 6). Literature 1). [Prior Art Literature] [Patent Document]
[專利文獻1] 國際公開第2013/162019號 [專利文獻2] 國際公開第2016/006413號 [專利文獻3] 國際公開第2007/069765號 [專利文獻4] 國際公開第2014/201290號 [專利文獻5] 日本特開2017-218519號公報 [專利文獻6] 日本特開2017-202980號公報 [非專利文獻] [Patent Document 1] International Publication No. 2013/162019 [Patent Document 2] International Publication No. 2016/006413 [Patent Document 3] International Publication No. 2007/069765 [Patent Document 4] International Publication No. 2014/201290 [Patent Document 5] Japanese Patent Laid-Open No. 2017-218519 [Patent Document 6] Japanese Patent Laid-Open No. 2017-202980 [Non-patent literature]
[非專利文獻1] A. Takahashi, R. Goseki, K. Ito, H. Otsuka, ACS Macro Letters, 6, 1280(2017).[Non-Patent Document 1] A. Takahashi, R. Goseki, K. Ito, H. Otsuka, ACS Macro Letters, 6, 1280(2017).
[發明所欲解決之課題][Problem to be Solved by the Invention]
但,專利文獻1~6及非專利文獻1記載之自我修復材料之自我修復力並非係充分者。 因此,本發明係有鑑於上述問題・狀況所完成者,其目的在於提供一種具有優異自我修復力之材料。 [用以解決課題之手段] However, the self-healing power of the self-healing materials described in Patent Documents 1 to 6 and Non-Patent Document 1 is not sufficient. Therefore, the present invention was made in view of the above-mentioned problems and situations, and an object of the present invention is to provide a material having excellent self-healing ability. [Means to solve the problem]
本發明者等為了解決上述課題,對於上述問題之原因等進行精心研討之結果,發現具有特定構造之化合物即能解決上述課題,進而達成本發明。 即,本發明為如下述[1]~[9]所示。 In order to solve the above-mentioned problems, the inventors of the present invention intensively studied the causes of the above-mentioned problems and found that a compound having a specific structure can solve the above-mentioned problems, and thus arrived at the present invention. That is, the present invention is as shown in the following [1] to [9].
[1] 一種下述式(1)所示之化合物。[1] A compound represented by the following formula (1).
式(1)中,R 1、R 2、R 3及R 4係各自獨立表示氫原子、碳原子數1~50之聚合性官能基或碳原子數1~50之烷基。該烷基亦可具有雜原子。該烷基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代。該烷基中之氫原子之一部分亦可被鹵素原子所取代。n1表示1~10之整數。R 1、R 2、R 3及R 4之至少一個表示碳原子數1~50之聚合性官能基。但,去除R 1、R 2、R 3及R 4之任意兩個連結而成為環構造之化合物。 In formula (1), R 1 , R 2 , R 3 and R 4 each independently represent a hydrogen atom, a polymerizable functional group with 1 to 50 carbon atoms, or an alkyl group with 1 to 50 carbon atoms. The alkyl group may also have heteroatoms. Part of the methylene group in the alkyl group may be substituted by an ether bond, thioether bond, ester bond, amide bond, imide bond or carbonyl. Part of the hydrogen atoms in the alkyl group may be substituted by halogen atoms. n1 represents an integer from 1 to 10. At least one of R 1 , R 2 , R 3 and R 4 represents a polymerizable functional group having 1 to 50 carbon atoms. However, any two of R 1 , R 2 , R 3 and R 4 are removed to form a compound having a ring structure.
[2] 如[1]之化合物,其中碳原子數1~50之聚合性官能基為選自由乙烯基、烯丙基、丙烯醯基、甲基丙烯醯基、羥基、異氰酸酯基、胺基、醯胺基、環氧基、環氧丙烷基、環硫化物基、羧基、雜芳基、巰基、包含羧酸酐構造之基及包含環狀醯亞胺構造之基所成群之作用基與烴基鍵結而成之基,該烴基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代,該聚合性官能基中之氫原子之一部亦可被鹵素原子所取代。[2] The compound as described in [1], wherein the polymerizable functional group having 1 to 50 carbon atoms is selected from the group consisting of vinyl, allyl, acryl, methacryl, hydroxyl, isocyanate, amine, Amide group, epoxy group, epoxypropylene group, episulfide group, carboxyl group, heteroaryl group, mercapto group, groups containing carboxylic acid anhydride structures and groups containing cyclic imide structures and hydrocarbon groups A group formed by bonding, a part of the methylene group in the hydrocarbon group can also be substituted by an ether bond, a thioether bond, an ester bond, an amide bond, an imide bond or a carbonyl group, and the hydrogen in the polymerizable functional group Part of the atoms may also be replaced by halogen atoms.
[3] 如[1]之化合物,其中碳原子數1~50之聚合性官能基為下述式(L-1)所示之基。[3] The compound according to [1], wherein the polymerizable functional group having 1 to 50 carbon atoms is a group represented by the following formula (L-1).
式(L-1)中,L 1及L 2係各自獨立表示碳原子數1~5之烷二基。n表示0~5之整數。n為2以上之整數時,複數之L 1可為相同之基,亦可為相異之基。*表示與式(1)中之氮原子之鍵結位置。 In the formula (L-1), L 1 and L 2 each independently represent an alkanediyl group having 1 to 5 carbon atoms. n represents an integer from 0 to 5. When n is an integer of 2 or more, L 1 of the plural number may be the same base or different bases. * represents the bonding position with the nitrogen atom in the formula (1).
[4] 一種硬化性組成物,其係包含如[1]~[3]中任一項之化合物。[4] A curable composition comprising the compound according to any one of [1] to [3].
[5] 如[4]之硬化性組成物,其中更包含選自由硬化劑及聚合起始劑所成群之至少1種。[5] The curable composition according to [4], further comprising at least one member selected from the group consisting of a curing agent and a polymerization initiator.
[6] 如[5]之硬化性組成物,其中硬化劑為選自由胺化合物、醯胺化合物、酸酐化合物、硫醇化合物、酚化合物、咪唑化合物及潛伏性硬化劑所成群之至少1種。[6] The curable composition according to [5], wherein the curing agent is at least one selected from the group consisting of amine compounds, amide compounds, acid anhydride compounds, thiol compounds, phenol compounds, imidazole compounds and latent curing agents .
[7] 如[5]之硬化性組成物,其中聚合起始劑為陽離子聚合起始劑或自由基聚合起始劑。[7] The curable composition according to [5], wherein the polymerization initiator is a cationic polymerization initiator or a radical polymerization initiator.
[8] 如[4]之硬化性組成物,其係自我修復材料、表面塗覆劑、塗料、接著劑或電池用材料。 [9] 一種硬化物,其係使如[4]之硬化性組成物硬化而成。 [發明效果] [8] The curable composition of [4], which is a self-healing material, surface coating agent, paint, adhesive, or battery material. [9] A cured product obtained by hardening the curable composition described in [4]. [Invention effect]
根據本發明,可提供一種具有優異自我修復力之材料。According to the present invention, a material having excellent self-healing power can be provided.
以下,詳細說明本發明之實施形態。 首先,說明關於本發明之化合物。尚且,本說明書中,有將在構造中具有環氧乙烷(oxirane)環之化合物記載為環氧化合物的情況。 Embodiments of the present invention will be described in detail below. First, the compound of the present invention will be described. Furthermore, in this specification, a compound having an oxirane (oxirane) ring in its structure may be described as an epoxy compound.
<化合物> 本發明之化合物為下述式(1)所示者。 <Compound> The compound of the present invention is represented by the following formula (1).
式(1)中之R 1、R 2、R 3及R 4係各自獨立表示氫原子、碳原子數1~50之聚合性官能基或碳原子數1~50之烷基。該烷基亦可具有雜原子。該烷基中之亞甲基(-CH 2-)之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代。該烷基中之氫原子之一部分亦可被鹵素原子所取代。n1表示1~10之整數。R 1、R 2、R 3及R 4之至少一個表示碳原子數1~50之聚合性官能基。但,去除R 1、R 2、R 3及R 4之任意兩個連結而成為環構造之化合物。 R 1 , R 2 , R 3 and R 4 in formula (1) each independently represent a hydrogen atom, a polymerizable functional group with 1 to 50 carbon atoms, or an alkyl group with 1 to 50 carbon atoms. The alkyl group may also have heteroatoms. Part of the methylene group (-CH 2 -) in the alkyl group may also be substituted by an ether bond, thioether bond, ester bond, amide bond, imide bond or carbonyl. Part of the hydrogen atoms in the alkyl group may be substituted by halogen atoms. n1 represents an integer from 1 to 10. At least one of R 1 , R 2 , R 3 and R 4 represents a polymerizable functional group having 1 to 50 carbon atoms. However, any two of R 1 , R 2 , R 3 and R 4 are removed to form a compound having a ring structure.
本說明書中,作為雜原子,可舉出如,氮原子、氧原子、矽原子、氟原子、硫原子、磷原子、鋁原子及硒原子。In the present specification, examples of heteroatoms include nitrogen atoms, oxygen atoms, silicon atoms, fluorine atoms, sulfur atoms, phosphorus atoms, aluminum atoms, and selenium atoms.
從化合物之純化為容易之觀點,n1係以1~4之整數為佳,以1為較佳。In view of the ease of purification of the compound, n1 is preferably an integer of 1 to 4, more preferably 1.
作為式(1)中之R 1、R 2、R 3及R 4所示之碳原子數1~50之烷基,可舉出例如,甲基、乙基、丙基、異丙基、丁基、sec-丁基、異丁基、tert-丁基、戊基、2-戊基、3-戊基、異戊基、己基、2-己基、3-己基、環戊基、環己基、庚基、異庚基、tert-庚基、n-辛基、異辛基、tert-辛基、2-乙基己基、壬基、異壬基、癸基、十二基(月桂基)、十三基、十四基基(肉豆蔻基)、十五基、十六基(棕櫚基)、十七基、十八基(硬脂醯基)、二十基、二十一基、二十二基、二十三基、二十四基、二十五基、二十六基、二十七基、二十八基、二十九基或三十基(蜜蠟基(myricyl)、蠟酸基(mericyl))等。 As an alkyl group having 1 to 50 carbon atoms represented by R 1 , R 2 , R 3 and R 4 in formula (1), for example, methyl, ethyl, propyl, isopropyl, butyl base, sec-butyl, isobutyl, tert-butyl, pentyl, 2-pentyl, 3-pentyl, isopentyl, hexyl, 2-hexyl, 3-hexyl, cyclopentyl, cyclohexyl, Heptyl, isoheptyl, tert-heptyl, n-octyl, isooctyl, tert-octyl, 2-ethylhexyl, nonyl, isononyl, decyl, dodecyl (lauryl), Tridecyl, tetradecyl (myristyl), pentadecyl, hexadecyl (palmityl), heptadecyl, octadecyl (stearyl), eicosyl, hexadecyl, di Dodecyl, 23 bases, 24 bases, 25 bases, 26 bases, 27 bases, 28 bases, 29 bases or 30 bases (myricyl, Wax acid group (mericyl)) and so on.
作為式(1)中之R 1、R 2、R 3及R 4所示之碳原子數1~50之聚合性官能基,可舉出如,選自由乙烯基、烯丙基、丙烯醯基、甲基丙烯醯基、羥基、異氰酸酯基、胺基、醯胺基、環氧基、環氧丙烷基、環硫化物基、羧基、雜芳基、巰基、包含羧酸酐構造之基及包含環狀醯亞胺構造之基所成群之作用基與烴基連結而成之基。該烴基中之亞甲基(-CH 2-)之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代,碳原子數1~50之聚合性官能基中之氫原子之一部亦可被鹵素原子所取代。 Examples of polymerizable functional groups having 1 to 50 carbon atoms represented by R 1 , R 2 , R 3 and R 4 in formula (1) include, for example, those selected from vinyl, allyl, and acryl groups. , methacryl group, hydroxyl group, isocyanate group, amine group, amido group, epoxy group, epoxypropylene group, episulfide group, carboxyl group, heteroaryl group, mercapto group, group containing carboxylic acid anhydride structure and containing ring The base formed by linking the functional group formed by the base of the imide structure and the hydrocarbon group. Part of the methylene group (-CH 2 -) in the hydrocarbon group can also be substituted by an ether bond, thioether bond, ester bond, amide bond, imide bond or carbonyl group, polymerizable with 1 to 50 carbon atoms Part of the hydrogen atoms in the functional group may be substituted by a halogen atom.
作為作用基之異氰酸酯基為-N=C=O所示者。The isocyanate group as the active group is represented by -N=C=O.
作為作用基之胺基為-NR 9R 10所示者,R 9及R 10表示氫原子或碳原子數1~6之烷基。作為該烷基,可舉出如在例示作為R 1、R 2、R 3及R 4所示之烷基當中,碳原子數為1~6者。從會展現更加優異之自我修復力的觀點,R 9及R 10係以各自獨立為氫原子或碳原子數1~3之烷基為佳,以氫原子、甲基或乙基為較佳。 The amine group as the active group is represented by -NR 9 R 10 , and R 9 and R 10 represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. Examples of the alkyl group include those having 1 to 6 carbon atoms among the alkyl groups exemplified as R 1 , R 2 , R 3 and R 4 . From the standpoint of exhibiting more excellent self-healing ability, R 9 and R 10 are each independently preferably a hydrogen atom or an alkyl group with 1 to 3 carbon atoms, preferably a hydrogen atom, methyl or ethyl.
作為作用基之醯胺基為-(C=O)-NR 11R 12所示者,R 11及R 12表示氫原子或碳原子數1~6之烷基。作為該烷基,可舉出如在例示作為R 1、R 2、R 3及R 4所示之烷基當中,碳原子數為1~6者。從會展現更加優異之自我修復力的觀點,R 11及R 12係以各自獨立為氫原子或碳原子數1~3之烷基為佳,以氫原子、甲基或乙基為較佳。 The amido group as an active group is represented by -(C=O)-NR 11 R 12 , and R 11 and R 12 represent a hydrogen atom or an alkyl group having 1 to 6 carbon atoms. Examples of the alkyl group include those having 1 to 6 carbon atoms among the alkyl groups exemplified as R 1 , R 2 , R 3 and R 4 . From the viewpoint of exhibiting more excellent self-healing ability, R 11 and R 12 are each independently preferably a hydrogen atom or an alkyl group with 1 to 3 carbon atoms, preferably a hydrogen atom, a methyl group or an ethyl group.
作為作用基之羧基也可為在構造中包含具有羧基之化合物的基。作為具有羧基之化合物,可舉出例如,馬來酸、琥珀酸、酞酸、富馬酸、戊二酸、己二酸、伊康酸等之二羧酸化合物或檸檬酸或烏頭酸等之三羧酸化合物等。The carboxyl group as an active group may be a group including a compound having a carboxyl group in its structure. Examples of compounds having a carboxyl group include dicarboxylic acid compounds such as maleic acid, succinic acid, phthalic acid, fumaric acid, glutaric acid, adipic acid, and itaconic acid, or dicarboxylic acid compounds such as citric acid or aconitic acid. Tricarboxylic acid compounds, etc.
當作作為作用基之雜芳基,可舉出例如,噻吩基、呋喃基、吡咯基、咪唑基、吡唑基、噻唑基、異噻唑基、1,2,3-噁二唑基、1,2,4-噁二唑基、1,2,5-噁二唑基、1,3,4-噁二唑基、1,2,3-噻二唑基、1,2,4-噻二唑基、1,2,5-噻二唑基、1,3,4-噻二唑基、異噻唑-3-基、異噻唑-4-基、異噻唑-5-基、噁唑-2-基、噁唑-4-基、噁唑-5-基、異噁唑-3-基、異噁唑-4-基、異噁唑-5-基、1,2,4-三唑-3-基、1,2,4-三唑-5-基、1,2,3-三唑-4-基、1,2,3-三唑-5-基、四唑基、2-吡嗪-2-基、吡嗪-4-基、吡嗪-5-基、2-嘧啶-2-基、4-嘧啶-2-基、5-嘧啶-2-基等。As the heteroaryl group as the active group, for example, thienyl, furyl, pyrrolyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, 1,2,3-oxadiazolyl, 1 ,2,4-oxadiazolyl, 1,2,5-oxadiazolyl, 1,3,4-oxadiazolyl, 1,2,3-thiadiazolyl, 1,2,4-thiazolyl Oxadiazolyl, 1,2,5-thiadiazolyl, 1,3,4-thiadiazolyl, isothiazol-3-yl, isothiazol-4-yl, isothiazol-5-yl, oxazole- 2-yl, oxazol-4-yl, oxazol-5-yl, isoxazol-3-yl, isoxazol-4-yl, isoxazol-5-yl, 1,2,4-triazole -3-yl, 1,2,4-triazol-5-yl, 1,2,3-triazol-4-yl, 1,2,3-triazol-5-yl, tetrazolyl, 2- Pyrazin-2-yl, pyrazin-4-yl, pyrazin-5-yl, 2-pyrimidin-2-yl, 4-pyrimidin-2-yl, 5-pyrimidin-2-yl, etc.
當作作為作用基之包含羧酸酐構造之基,可舉出例如,無水馬來酸、無水琥珀酸、無水酞酸、無水戊二酸、無水己二酸或無水伊康酸等之在構造中包含羧酸酸酐之基。As the active group containing a carboxylic anhydride structure, for example, anhydrous maleic acid, anhydrous succinic acid, anhydrous phthalic acid, anhydrous glutaric acid, anhydrous adipic acid or anhydrous itaconic acid in the structure Contains carboxylic acid anhydride groups.
當作作為作用基之包含環狀醯亞胺構造之基,可舉出例如,馬來醯亞胺、琥珀酸醯亞胺或酞酸醯亞胺等之在構造中包含環狀醯亞胺化合物之基。As the group containing a cyclic imide structure as the active group, for example, compounds containing a cyclic imide in the structure, such as maleimide, succinimide, or phthalimide, can be mentioned. foundation.
本發明之化合物之作用基中之氫原子之一部亦可被鹵素原子、烷基、烯基或該等之組合所取代。Part of the hydrogen atoms in the active groups of the compounds of the present invention may also be substituted by halogen atoms, alkyl groups, alkenyl groups or combinations thereof.
與作用基連結之烴基係達成將作用基與式(1)所示之化合物之氮原子予以連結之作用。作為該烴基,可舉出如,直鏈狀烷基、分枝狀烷基或包含脂環式化合物之烷基。烴基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代。烴基中之氫原子之一部分亦可被鹵素原子所取代。The hydrocarbon group linked to the active group serves to link the active group to the nitrogen atom of the compound represented by formula (1). Examples of the hydrocarbon group include linear alkyl groups, branched alkyl groups, and alkyl groups containing alicyclic compounds. Part of the methylene group in the hydrocarbon group may be substituted by an ether bond, thioether bond, ester bond, amide bond, imide bond or carbonyl. Part of the hydrogen atoms in the hydrocarbon group may be substituted by halogen atoms.
作為烴基中之脂環式化合物,可舉出如,環丙烷、環丁烷、環戊烷、環己烷、環庚烷、環辛烷、環癸烷、環十一烷或環十二烷等之單環式烷、雙環十一烷、十氫萘、十氫萘或降莰烷等之二環式烷、三環十一烷或三環十三烷等之三環式烷、四環二十八烷或四環十三烷等之四環式烷等。Examples of the alicyclic compound in the hydrocarbon group include cyclopropane, cyclobutane, cyclopentane, cyclohexane, cycloheptane, cyclooctane, cyclodecane, cycloundecane or cyclododecane Monocyclic alkanes such as bicycloundecane, decahydronaphthalene, decahydronaphthalene or norbornane, etc. Tetracycloalkanes such as octacosane or tetracyclotridecane, etc.
碳原子數1~50之聚合性官能基中,作用基與烴基之連結係藉由:以上述作用基來取代烴基中之氫原子之一部分;環氧基、環氧丙烷基、環硫化物(episulfide)基等之具有飽和脂環構造之作用基與烴基中之脂環式化合物共同具有環之一部分來形成縮合環;或,具有飽和脂環構造之作用基與烴基中之脂環式化合物隔著一部分碳原子來結合而形成螺構造來進行。在一個碳原子數1~50之聚合性官能基中,亦可具有複數個連結作用基與烴基之場所。在一個碳原子數1~50之聚合性官能基中,具有複數個連結作用基與烴基之場所的情況,個別之連結構造可為相同者,亦可為相異者。Among the polymerizable functional groups with 1 to 50 carbon atoms, the connection between the active group and the hydrocarbon group is through: replacing a part of the hydrogen atoms in the hydrocarbon group with the above-mentioned active group; epoxy group, epoxypropylene group, episulfide ( The functional group having a saturated alicyclic structure such as an episulfide) group and the alicyclic compound in the hydrocarbon group share a part of the ring to form a condensed ring; or, the functional group having a saturated alicyclic structure is separated from the alicyclic compound in the hydrocarbon group It is carried out by combining some carbon atoms to form a spiro structure. In one polymerizable functional group with 1 to 50 carbon atoms, there may be a plurality of sites for linking the functional group and the hydrocarbon group. In the case where one polymerizable functional group having 1 to 50 carbon atoms has a plurality of sites for linking the functional group and the hydrocarbon group, the individual linking structures may be the same or different.
從本發明之效果變得顯著之觀點,本發明之化合物中,作用基係以具有丙烯醯基、甲基丙烯醯基、環氧基、環氧丙烷基、環硫化物基或羥基之碳原子數1~50之聚合性官能基為佳,作用基係以具有丙烯醯基、甲基丙烯醯基、環氧基或羥基之碳原子數1~50之聚合性官能基為較佳。From the viewpoint that the effect of the present invention becomes remarkable, in the compound of the present invention, the functional group is a carbon atom having an acryl group, a methacryl group, an epoxy group, a propylene oxide group, an episulfide group or a hydroxyl group. A polymerizable functional group with a number of 1-50 is preferable, and a polymerizable functional group with an acryl group, a methacryl group, an epoxy group or a hydroxyl group with a carbon number of 1-50 is more preferable.
作為較佳碳原子數1~50之聚合性官能基之具體例,可舉出如,羥基乙基、丙烯醯氧基乙基、甲基丙烯醯氧基乙基、烯丙基、2-(7-氧雜雙環[4.1.0]庚-3-基)乙酸酯乙基、2-(4-甲基-7-氧雜雙環[4.1.0]庚-3-基)乙酸酯乙基、2-(3-氧雜三環[3.2.1.0 2.4]辛-6-基)乙酸酯乙基、1H-咪唑-1-羧酸酯乙基、甘胺酸酯乙基、甲基甘胺酸酯乙基、二甲基甘胺酸酯乙基、哌啶-4-羧酸酯乙基、巰基乙酸酯乙基、異氰酸酯甲氧基乙基、2,5-二氧雜四氫呋喃-3-羧酸酯乙基、1,3-二氧雜-1,3-二氫異苯並呋喃-5-羧酸酯-乙基、2-(噻丙環-2-基甲氧基)乙基、甲基丙烯醯氧基乙基胺基羰氧基乙基、下述式(L-1)所示之基等。該等之中,從本發明之效果變得顯著之觀點,作為碳原子數1~50之聚合性官能基,以下述式(L-1)所示之基為較佳。 Specific examples of polymerizable functional groups with preferably 1 to 50 carbon atoms include, for example, hydroxyethyl, acryloxyethyl, methacryloxyethyl, allyl, 2-( 7-oxabicyclo[4.1.0]hept-3-yl)acetate ethyl, 2-(4-methyl-7-oxabicyclo[4.1.0]hept-3-yl)acetate ethyl Base, 2-(3-oxatricyclo[3.2.1.0 2.4 ]oct-6-yl)ethyl acetate, 1H-imidazole-1-carboxylate ethyl, glycinate ethyl, methyl Ethyl glycinate, ethyl dimethylglycinate, ethyl piperidine-4-carboxylate, ethyl thioglycolate, methoxyethyl isocyanate, 2,5-dioxatetrahydrofuran -3-Carboxylate ethyl, 1,3-dioxa-1,3-dihydroisobenzofuran-5-carboxylate-ethyl, 2-(thiapropane-2-ylmethoxy ) ethyl group, methacryloxyethylaminocarbonyloxyethyl group, a group represented by the following formula (L-1), etc. Among these, from the viewpoint that the effect of the present invention becomes remarkable, a group represented by the following formula (L-1) is preferable as the polymerizable functional group having 1 to 50 carbon atoms.
式(L-1)中,L 1及L 2係各自獨立表示碳原子數1~5之烷二基。L 1及L 2可為相同之基亦可為相異之基。n表示0~5之整數。n為2以上之整數時,複數之L 1可為相同之基亦可為相異之基。*表示與式(1)中之氮原子之鍵結位置。 In the formula (L-1), L 1 and L 2 each independently represent an alkanediyl group having 1 to 5 carbon atoms. L 1 and L 2 may be the same group or different groups. n represents an integer from 0 to 5. When n is an integer of 2 or more, the plural L 1 may be the same group or different groups. * represents the bonding position with the nitrogen atom in the formula (1).
作為L 1及L 2所示之碳原子數1~5之烷二基,可舉出如,甲烷二基、1,2-乙烷二基、1,2-丙烷二基、1,3-丙烷二基、1,4-丁烷二基、1,5-戊烷二基等。從本發明之效果變得顯著之觀點,以L 1及L 2係各自獨立為具有甲烷二基、1,2-乙烷二基、1,2-丙烷二基或1,3-丙烷二基之聚合性官能基的化合物為佳,以L 1及L 2係各自獨立為具有1,2-乙烷二基或1,2-丙烷二基之聚合性官能基的化合物為較佳。 Examples of the alkanediyl groups having 1 to 5 carbon atoms represented by L1 and L2 include methanediyl, 1,2-ethanediyl, 1,2-propanediyl, 1,3- Propanediyl, 1,4-butanediyl, 1,5-pentanediyl, etc. From the point of view that the effect of the present invention becomes remarkable, the L1 and L2 systems each independently have methanediyl, 1,2-ethanediyl, 1,2-propanediyl or 1,3-propanediyl A compound having a polymerizable functional group is preferred, and a compound in which L 1 and L 2 are each independently a polymerizable functional group having a 1,2-ethanediyl group or a 1,2-propanediyl group is preferred.
從本發明之效果變得顯著之觀點,n係以0~3之整數為佳,以0~2之整數為較佳,以0或1為最佳。From the standpoint that the effect of the present invention becomes remarkable, n is preferably an integer of 0-3, more preferably an integer of 0-2, most preferably 0 or 1.
作為式(L-1)所示之基之具體例,可舉出如,環氧丙氧基甲基、環氧丙氧基乙氧基乙基、環氧丙氧基乙氧基乙氧基乙基或環氧丙氧基異丙氧基異丙基等。該等之中,從本發明之效果變得顯著之觀點,以環氧丙氧基乙基或環氧丙氧基乙氧基乙氧基乙基為為佳。Specific examples of the group represented by formula (L-1) include, for example, glycidoxymethyl, glycidoxyethoxyethyl, glycidoxyethoxyethoxy Ethyl or glycidoxy isopropoxy isopropyl, etc. Among them, a glycidoxyethyl group or a glycidoxyethoxyethoxyethyl group is preferable from the viewpoint that the effect of the present invention becomes remarkable.
從可取得具有更加優異自我修復力之化合物之觀點,聚合性官能基之碳原子數係以1~30之範圍為佳,以1~20之範圍為較佳,1~10之範圍為更佳。From the viewpoint of obtaining compounds with more excellent self-healing ability, the number of carbon atoms in the polymerizable functional group is preferably in the range of 1-30, more preferably in the range of 1-20, and more preferably in the range of 1-10 .
從可取得具有更加優異自我修復力之化合物之觀點,以R 1、R 2、R 3及R 4之至少兩個為碳原子數1~50之聚合性官能基為佳,以R 1、R 2、R 3及R 4之兩個為碳原子數1~50之聚合性官能基為較佳。R 1、R 2、R 3及R 4之至少兩個為碳原子數1~50之聚合性官能基之情況,個別之聚合性官能基可為相同者,亦可為相異者。R 1、R 2、R 3及R 4之至少兩個為碳原子數1~50之聚合性官能基之情況,從可取得具有更加優異自我修復力之化合物之觀點,以R 1及R 2之至少一個與R 3及R 4之至少一個為、碳原子數1~50之聚合性官能基為佳。 From the viewpoint of obtaining a compound with more excellent self-healing ability, at least two of R 1 , R 2 , R 3 and R 4 are preferably polymerizable functional groups with 1 to 50 carbon atoms, and R 1 , R 2. Two of R 3 and R 4 are preferably polymerizable functional groups with 1 to 50 carbon atoms. When at least two of R 1 , R 2 , R 3 and R 4 are polymerizable functional groups having 1 to 50 carbon atoms, the individual polymerizable functional groups may be the same or different. When at least two of R 1 , R 2 , R 3 and R 4 are polymerizable functional groups with 1 to 50 carbon atoms, from the viewpoint of obtaining a compound with more excellent self-healing ability, R 1 and R 2 At least one of R3 and R4 is preferably a polymerizable functional group having 1 to 50 carbon atoms.
又,R 1及R 2之組合,與R 3及R 4之組合亦可為相異,但從可取得具有更加優異自我修復力之化合物之觀點,以相同為佳。 Also, the combination of R1 and R2 may be different from the combination of R3 and R4 , but they are preferably the same from the viewpoint of obtaining a compound with a more excellent self-healing ability.
尚且,作為R 1及R 2之組合,與R 3及R 4之組合為相同之化合物,可舉出例如,後述之化合物No.1~No.3、No.5~No.10、No.12~No.19、No.21~No.23、No.25及No.26。又,作為R 1及R 2之組合,與R 3及R 4之組合為相異之化合物,可舉出例如,後述之化合物No.4、No.11、No.20及No.24。 Furthermore, the combination of R1 and R2 is the same compound as the combination of R3 and R4 , for example, compounds No.1 to No.3, No.5 to No.10, and No. 12~No.19, No.21~No.23, No.25 and No.26. Also, the combination of R 1 and R 2 is different from the combination of R 3 and R 4 , for example, compounds No. 4, No. 11, No. 20 and No. 24 described below.
作為上述式(1)所示之化合物之具體例,可舉出如下述No.1~No.26,但本發明並非係受到該等化合物所限定者。尚且,「tBu」表示tert-丁基。Specific examples of the compound represented by the above formula (1) include the following No.1 to No.26, but the present invention is not limited to these compounds. Also, "tBu" means tert-butyl.
式(1)所示之化合物係能以例如,對具有碳原子數1~50之聚合性官能基之胺基化合物添加乙酸鈉及二甲基甲醯胺,在氮環境下滴下二氯化二硫,過濾分離產生之沉澱並予以回收,藉由水洗、濃縮來製造所欲之化合物的方法,或,使具有羥基之二胺基二硫醚化合物,與對應之具有碳原子數1~50之聚合性反應基之化合物進行反應的方法來進行製造。The compound represented by formula (1) can be obtained by, for example, adding sodium acetate and dimethylformamide to an amino compound having a polymerizable functional group with carbon atoms of 1 to 50, and dropping dichloride dichloride under a nitrogen environment. Sulfur, the method of filtering and separating the produced precipitate and recovering it, washing with water and concentrating to produce the desired compound, or making the diaminodisulfide compound having a hydroxyl group and the corresponding one having 1 to 50 carbon atoms It is produced by reacting the compound of the polymerizable reactive group.
更具體而言,在製造上述化合物No.1之情況,可藉由對反應容器添加2-(tert-丁基胺基)乙基甲基丙烯酸酯、乙酸鈉及二甲基甲醯胺後,滴下二氯化硫使其反應,餾除溶劑並使用乙酸丁酯及水進行萃取後,進行水洗、乾燥的方法來取得。More specifically, in the case of producing the above compound No.1, after adding 2-(tert-butylamino)ethyl methacrylate, sodium acetate and dimethylformamide to the reaction vessel, It is obtained by dropping sulfur dichloride to react, distilling off the solvent, extracting with butyl acetate and water, washing with water, and drying.
本發明之化合物為具有多硫醚骨架者,由於多硫醚骨架之硫原子間之化學鍵會因加熱或光照射等而容易地斷裂-再鍵結,從而能展現優異之自我修復力。又,本發明之化合物係能以簡便方法來製造。 優異自我修復力係指例如,即使損傷為大仍能自我修復;能自我修復之次數為多;從損傷之狀態來進行自我修復後,仍能回復充足力學性強度;等之性能。尤其,本發明之化合物具有能修復成變回損傷前之材料強度的優異自我修復力。又,具有自我修復力之材料係能期待緩和在硬化時產生之應力的效果。 The compound of the present invention has a polythioether skeleton, and since the chemical bond between the sulfur atoms of the polythioether skeleton is easily broken and rebonded by heating or light irradiation, it can exhibit excellent self-healing ability. In addition, the compound of the present invention can be produced by a simple method. Excellent self-healing ability means, for example, that it can self-repair even if the damage is large; the number of self-repairs can be large; after self-repairing from the damaged state, it can still restore sufficient mechanical strength; etc. performance. In particular, the compounds of the present invention have excellent self-healing power capable of restoring back to the strength of the material before damage. In addition, a material having self-healing power can be expected to have the effect of alleviating the stress generated during hardening.
<環氧樹脂> 可使用本發明之化合物來製造環氧樹脂。例如,可藉由具有使下述式(2)所示之化合物與表鹵醇(epihalohydrin)類反應之步驟的製造方法來製造環氧樹脂。本發明中,環氧樹脂不僅包含使式(2)所示之化合物與表鹵醇類反應時產生之生成物及副生成物,也能包含原料之式(2)所示之化合物或表鹵醇類作為成分。本發明中,使式(2)所示之化合物與表鹵醇類反應而生成之生成物,由於本發明之效果會變得顯著,故以包含環氧基之上述式(1)所示之化合物為較佳。 <Epoxy resin> The compounds of the present invention can be used to make epoxy resins. For example, an epoxy resin can be manufactured by the manufacturing method which has the process of making the compound represented by following formula (2) react with epihalohydrins (epihalohydrins). In the present invention, the epoxy resin includes not only the products and by-products produced when the compound represented by the formula (2) is reacted with epihalohydrins, but also the compound represented by the formula (2) or the epihalohydrin as a raw material. Alcohols as ingredients. In the present invention, the product obtained by reacting the compound represented by the formula (2) with epihalohydrins is represented by the above formula (1) containing an epoxy group, since the effect of the present invention will become remarkable. compounds are preferred.
(式(2)中,R 5、R 6、R 7及R 8係各自獨立為氫原子或可具有羥基之碳原子數1~50之烷基。該烷基亦可具有雜原子。該烷基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代。該烷基中之氫原子之一部分亦可被鹵素原子所取代。n2表示1~10之整數。R 5、R 6、R 7及R 8之至少一個表示具有羥基之碳原子數1~50之烷基。但,去除R 5、R 6、R 7及R 8之任意兩個連結而成為環構造之化合物。) (In formula (2), R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom or an alkyl group with 1 to 50 carbon atoms that may have a hydroxyl group. The alkyl group may also have a heteroatom. The alkane A part of the methylene group in the group can also be substituted by an ether bond, a thioether bond, an ester bond, an amide bond, an imide bond or a carbonyl group. A part of the hydrogen atom in the alkyl group can also be substituted by a halogen atom .n2 represents an integer of 1 to 10. At least one of R 5 , R 6 , R 7 and R 8 represents an alkyl group with 1 to 50 carbon atoms having a hydroxyl group. However, removing R 5 , R 6 , R 7 and R Any two of 8 are connected to form a compound with a ring structure.)
式(2)中之R 5、R 6、R 7及R 8所示之碳原子數1~50之烷基係可舉出如,與作為R 1、R 2、R 3及R 4所示之碳原子數1~50之烷基所例示者為相同者。R 5、R 6、R 7及R 8所示之具有羥基之碳原子數1~50之烷基係表示上述之烷基中之氫原子之一部分被羥基所取代之基。該烷基亦可具有雜原子,該烷基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代,烷基中之氫原子之一部分亦可被鹵素原子所取代。從硬化物之特性優異之觀點,以R 5及R 6之至少一個,與R 7及R 8之至少一個為具有羥基之碳原子數1~50之烷基為佳。 The alkyl groups having 1 to 50 carbon atoms represented by R 5 , R 6 , R 7 and R 8 in the formula (2) include, for example, those represented by R 1 , R 2 , R 3 and R 4 The examples of the alkyl group having 1 to 50 carbon atoms are the same. The C1-50 alkyl groups having hydroxyl groups represented by R 5 , R 6 , R 7 and R 8 represent groups in which a part of the hydrogen atoms in the above-mentioned alkyl groups are substituted by hydroxyl groups. The alkyl group may also have a heteroatom, and a part of the methylene group in the alkyl group may also be substituted by an ether bond, a thioether bond, an ester bond, an amide bond, an imide bond or a carbonyl group, and the hydrogen in the alkyl group Part of the atoms may also be substituted by halogen atoms. From the standpoint of excellent properties of the cured product, at least one of R5 and R6 , and at least one of R7 and R8 is preferably an alkyl group with 1 to 50 carbon atoms having a hydroxyl group.
從化合物之純化為容易之觀點,n2係以1~4之整數為佳,以1為較佳。In view of the ease of purification of the compound, n2 is preferably an integer of 1 to 4, more preferably 1.
作為上述表鹵醇類,可舉出如,表氯醇、β-甲基表氯醇、表溴醇、β-甲基表溴醇等。該等之中,從取得容易性或經濟性之觀點,以表氯醇為佳。Examples of the epihalohydrins include epichlorohydrin, β-methylepichlorohydrin, epibromohydrin, and β-methylepibromohydrin. Among them, epichlorohydrin is preferable from the viewpoint of easy acquisition and economical efficiency.
作為環氧樹脂之製造方法之具體例,可舉出例如,在鹼、路易斯酸或相轉移觸媒之存在下,如下述反應式1所示般,使式(2)所示之化合物與表氯醇進行反應的方法。從環氧樹脂之收率變高之觀點,上述反應係以在20℃~100℃之條件下進行為佳,以在30℃~80℃之條件下進行為較佳。尚且,下述反應式1中,R 6、R 8及n2之定義係與上述式(2)中之定義相同,m1及m2係各自獨立表示1~50之整數。 As a specific example of the production method of epoxy resin, for example, in the presence of a base, a Lewis acid or a phase transfer catalyst, as shown in the following reaction formula 1, the compound represented by the formula (2) is combined with the Chlorohydrin reaction method. From the standpoint of increasing the yield of epoxy resin, it is better to carry out the above reaction under the condition of 20°C~100°C, more preferably under the condition of 30°C~80°C. Furthermore, in the following reaction formula 1, the definitions of R 6 , R 8 and n2 are the same as those in the above formula (2), and m1 and m2 each independently represent an integer of 1-50.
作為上述反應所使用之鹼,可舉出例如,日本專利第5698072號記載之鹼等。作為上述反應所使用之路易斯酸及相轉移觸媒,可舉出例如,日本專利第5698072號記載之路易斯酸及相轉移觸媒等。As a base used for the said reaction, the base etc. which are described in Japanese Patent No. 5698072 are mentioned, for example. Examples of the Lewis acid and phase transfer catalyst used in the above reaction include those described in Japanese Patent No. 5698072 and the like.
又,上述反應中可使用以往公知之溶劑。作為上述反應能使用之溶劑,可舉出例如,日本專利第5698072號記載之溶劑等。In addition, conventionally known solvents can be used in the above reaction. As a solvent which can be used for the said reaction, the solvent etc. which are described in Japanese Patent No. 5698072 are mentioned, for example.
本發明之環氧樹脂之製造方法中之表鹵醇類之使用量在從可取得高純度環氧樹脂之觀點,相對於式(2)所示之化合物所含之羥基1莫耳而言,以成為1莫耳以上之量為佳,以成為1莫耳~20莫耳之量為較佳。上述鹼之使用量在從可取得高純度環氧樹脂之觀點,相對於式(2)所示之化合物所含之羥基1莫耳而言,以成為0.1莫耳~2.0莫耳之量為佳,以成為0.3莫耳~1.5莫耳之量為較佳。上述路易斯酸或相轉移觸媒之使用量在從可取得高純度環氧樹脂之觀點,相對於式(2)所示之化合物所含之羥基量而言,以成為0.01莫耳%~10莫耳%之量為佳,以成為0.2莫耳%~5莫耳%之量為較佳。The usage amount of the epihalohydrin in the manufacture method of epoxy resin of the present invention is from the viewpoint that can obtain high-purity epoxy resin, relative to the contained hydroxyl group 1 mole of the compound shown in formula (2), It is preferably in an amount of 1 mole or more, more preferably in an amount of 1 mole to 20 moles. The use amount of the above-mentioned base is from the viewpoint of obtaining high-purity epoxy resin, relative to 1 mole of hydroxyl contained in the compound represented by formula (2), it is better to become the amount of 0.1 mole to 2.0 mole , preferably in an amount of 0.3 mol to 1.5 mol. The use amount of the above-mentioned Lewis acid or phase transfer catalyst is from the viewpoint of obtaining high-purity epoxy resin, relative to the amount of hydroxyl groups contained in the compound represented by formula (2), to become 0.01 mol % ~ 10 mol The amount of mol% is preferable, and the amount of 0.2 mol% to 5 mol% is more preferable.
對於本發明之環氧樹脂加成不飽和一元酸而可取得鹼顯像性樹脂。Alkali-developable resin can be obtained by adding unsaturated monobasic acid to the epoxy resin of the present invention.
作為在此所使用之不飽和一元酸,可舉出例如,丙烯酸、甲基丙烯酸、巴豆酸、桂皮酸、山梨酸、羥基乙基甲基丙烯酸酯・馬來酸酯、羥基乙基丙烯酸酯・馬來酸酯、羥基丙基甲基丙烯酸酯・馬來酸酯、羥基丙基丙烯酸酯・馬來酸酯、二環戊二烯・馬來酸酯或具有1個羧基與2個以上之(甲基)丙烯醯基之多官能(甲基)丙烯酸酯等。本說明書中,(甲基)丙烯酸酯表示丙烯酸酯或甲基丙烯酸酯,(甲基)丙烯醯基表示丙烯醯基或甲基丙烯醯基。Examples of the unsaturated monobasic acid used here include acrylic acid, methacrylic acid, crotonic acid, cinnamic acid, sorbic acid, hydroxyethyl methacrylate maleate, hydroxyethyl acrylate Maleate, hydroxypropyl methacrylate・maleate, hydroxypropylacrylate・maleate, dicyclopentadiene・maleate, or one carboxyl group and two or more ( Multifunctional (meth)acrylate of meth)acryl group, etc. In this specification, (meth)acrylate means acrylate or methacrylate, and (meth)acryl means acryl or methacryl.
作為上述具有1個羧基與2個以上之(甲基)丙烯醯基之多官能(甲基)丙烯酸酯,可舉出例如,下述化合物等。As a polyfunctional (meth)acrylate which has the said 1 carboxyl group and 2 or more (meth)acryl groups, the following compound etc. are mentioned, for example.
從取得之鹼顯像性樹脂之感度變高之觀點,相對於本發明之環氧樹脂所含之1個環氧基,以不飽和一元酸所含之羧基會成為0.1~1個之比例來加成為佳,以成為0.3~1.0個之比例來加成為較佳。From the viewpoint that the sensitivity of the obtained alkali-developable resin becomes higher, the carboxyl group contained in the unsaturated monobasic acid will become a ratio of 0.1 to 1 with respect to one epoxy group contained in the epoxy resin of the present invention. It is better to add, and it is more preferable to add at a ratio of 0.3 to 1.0 pieces.
<硬化性組成物> 其次,說明關於本發明之硬化性組成物。 本發明之硬化性組成物為包含式(1)所示之化合物(以下亦有記載為「本發明之化合物」的情況)者。本發明之硬化性組成物可更含有能與本發明之化合物反應而形成硬化物之成分,較佳為選自由硬化劑及聚合起始劑所成群之至少1種。又,本發明之硬化性組成物可包含本發明之化合物以外之單體(以下亦有稱為「其他單體」的情況)作為硬化性單體。 <Hardening composition> Next, the curable composition of the present invention will be described. The curable composition of the present invention contains the compound represented by formula (1) (hereinafter also referred to as "the compound of the present invention"). The curable composition of the present invention may further contain a component capable of reacting with the compound of the present invention to form a cured product, preferably at least one selected from the group consisting of a curing agent and a polymerization initiator. In addition, the curable composition of the present invention may contain monomers other than the compound of the present invention (hereinafter also referred to as "other monomers") as curable monomers.
本發明之硬化性組成物在包含具有式(1)中之作用基為環氧基、環硫化物基或環氧丙烷基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含能與環氧基、環硫化物基或環氧丙烷基進行反應之公知硬化劑。作為硬化劑,若使用胺化合物、醯胺化合物、酸酐化合物、硫醇化合物、酚化合物、咪唑化合物或潛伏性硬化劑,則由於本發明之硬化性組成物之硬化反應會受到促進而為佳。硬化劑係可使用僅1種,亦可組合使用2種以上。The curable composition of the present invention contains a compound having a polymerizable functional group with 1 to 50 carbon atoms whose functional group in formula (1) is an epoxy group, an episulfide group or a propylene oxide group as a curable unit. In the case of a solid body, a known hardener capable of reacting with an epoxy group, an episulfide group or a propylene oxide group may be included. As a curing agent, it is preferable to use an amine compound, an amide compound, an acid anhydride compound, a mercaptan compound, a phenol compound, an imidazole compound or a latent curing agent because the curing reaction of the curable composition of the present invention is accelerated. The curing agent may be used alone or in combination of two or more.
當作作為上述硬化劑之胺化合物,可舉出例如,國際公開第2020/175321號記載之胺化合物等。Examples of the amine compound as the curing agent include amine compounds described in International Publication No. 2020/175321.
當作作為上述硬化劑之醯胺化合物,可舉出例如,國際公開第2020/175321號記載之醯胺化合物等。Examples of the amide compound as the curing agent include amide compounds described in International Publication No. 2020/175321.
當作作為上述硬化劑之酸酐化合物,可舉出例如,國際公開第2020/175321號記載之酸酐化合物。As an acid anhydride compound which is the said hardening|curing agent, the acid anhydride compound described in international publication 2020/175321 is mentioned, for example.
當作為上述硬化劑之硫醇化合物,可舉出例如,脂肪族硫醇化合物、芳香族硫醇化合物、脂肪族聚硫醇化合物、巰基羧酸酯化合物、巰基羧酸或巰基醚等。該等之中,從該硬化物會展現優異自我修復力之觀點,以二官能硫醇化合物為佳。作為二官能硫醇化合物,可舉出例如,國際公開第2020/175321號記載之化合物。又,從耐熱性之觀點,以下述式(3)所示之硫醇化合物為佳。Examples of the thiol compound of the curing agent include aliphatic thiol compounds, aromatic thiol compounds, aliphatic polythiol compounds, mercaptocarboxylate compounds, mercaptocarboxylic acids, and mercaptoethers. Among them, difunctional thiol compounds are preferable from the viewpoint that the cured product exhibits excellent self-healing power. Examples of the bifunctional thiol compound include compounds described in International Publication No. 2020/175321. Also, from the viewpoint of heat resistance, a thiol compound represented by the following formula (3) is preferable.
式(3)中,A表示碳原子數1~10之伸烷基,m3表示1~6之整數,X 1表示具有與m3同數量之價數之碳原子數1~20之飽和烴基。 In formula (3), A represents an alkylene group having 1 to 10 carbon atoms, m3 represents an integer of 1 to 6, and X1 represents a saturated hydrocarbon group having 1 to 20 carbon atoms having the same valence as m3.
X 1所示之具有與m3同數量之價數之碳原子數1~20之飽和烴基表示例如,從甲烷、乙烷、丙烷、異丙烷、丁烷、異丁烷、戊烷、己烷、庚烷、辛烷、壬烷、癸烷、十一烷、十二烷、十三烷、十四烷、十五烷或二十烷等之碳原子數1~20之烷、碳原子數3~20之脂環式化合物或該等之組合,去除與m3同數量之氫原子者。脂環式化合物表示滿足指定碳原子數之前述脂環式化合物。 The saturated hydrocarbon group with 1 to 20 carbon atoms having the same valence as m3 represented by X1 represents, for example, methane, ethane, propane, isopropane, butane, isobutane, pentane, hexane, C1-20 alkanes such as heptane, octane, nonane, decane, undecane, dodecane, tridecane, tetradecane, pentadecane or eicosane, and carbon number 3 ~20 alicyclic compounds or their combination, removing the same number of hydrogen atoms as m3. The alicyclic compound means the aforementioned alicyclic compound satisfying the specified number of carbon atoms.
當作作為上述硬化劑之酚化合物,可舉出例如,國際公開第2020/175321號記載之酚化合物等。Examples of the phenolic compound as the curing agent include phenolic compounds described in International Publication No. 2020/175321.
當作作為上述硬化劑之咪唑化合物,可舉出例如,2-乙基-4-甲基咪唑、2-甲基-1-苯基咪唑、2-十一基咪唑、2-苯基咪唑、1-(2-氰基乙基)-2-乙基-4-甲基咪唑、2,4-二胺基-6-[2-甲基咪唑基-(1)]乙基-s-三嗪、2-苯基咪唑啉、2,3-二氫-1H-吡咯[1,2-a]苯並咪唑、日本特開2015-017059號公報記載之咪唑化合物等。Examples of the imidazole compound as the curing agent include 2-ethyl-4-methylimidazole, 2-methyl-1-phenylimidazole, 2-undecylimidazole, 2-phenylimidazole, 1-(2-cyanoethyl)-2-ethyl-4-methylimidazole, 2,4-diamino-6-[2-methylimidazolyl-(1)]ethyl-s-tri oxazine, 2-phenylimidazoline, 2,3-dihydro-1H-pyrrole[1,2-a]benzimidazole, imidazole compounds described in JP-A-2015-017059, etc.
當作作為上述硬化劑之潛伏性硬化劑,可舉出例如,使聚胺化合物與環氧化合物反應而成之在分子內至少具有1個具有活性氫之胺基的變性胺潛伏性硬化劑、含酚系樹脂之潛伏性硬化劑、二氰二醯胺、變性聚胺、醯肼類、4,4’-二胺基二苯基碸、三氟化硼胺錯鹽、脲類、三聚氰胺、國際公開第2012/020572號及日本特開2014-177525號公報記載之化合物等。As the latent curing agent as the above-mentioned curing agent, for example, a denatured amine latent curing agent having at least one amine group having an active hydrogen in the molecule obtained by reacting a polyamine compound and an epoxy compound, Latent hardeners containing phenolic resins, dicyandiamide, denatured polyamines, hydrazines, 4,4'-diaminodiphenylsulfone, boron trifluoride ammonium zirconium salts, ureas, melamine, Compounds described in International Publication No. 2012/020572 and Japanese Patent Laid-Open No. 2014-177525, etc.
又,本發明之硬化性組成物在包含具有式(1)中之作用基為環氧基、環氧丙烷基或環硫化物基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含環氧化合物作為其他單體。In addition, the curable composition of the present invention contains a compound having a polymerizable functional group with 1 to 50 carbon atoms whose active group in formula (1) is an epoxy group, a propylene oxide group, or an episulfide group as a curable compound. In the case of a permanent monomer, an epoxy compound may be further included as another monomer.
作為上述環氧化合物,可舉出例如,脂環族環氧化合物、芳香族環氧化合物、脂肪族環氧化合物等。As said epoxy compound, an alicyclic epoxy compound, an aromatic epoxy compound, an aliphatic epoxy compound etc. are mentioned, for example.
作為上述脂環族環氧化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。作為脂環族環氧化合物之市售品,可舉出例如,UVR-6100、UVR-6105、UVR-6110、UVR-6128、UVR-6200(以上,Union Carbide公司製)、Ceroxide 2021、Ceroxide 2021P、Ceroxide 2081、Ceroxide 2083、Ceroxide 2085、Ceroxide 2000、Ceroxide 3000、Cyclomer A200、Cyclomer M100、Cyclomer M101、Epolead GT-301、Epolead GT-302、Epolead 401、Epolead403、ETHB、Epolead HD300或EHPE-3150(以上,(股)大賽璐製)等。脂環族環氧化合物之中,由於具有環氧環己烷(cyclohexene oxide)構造之環氧化合物會快速硬化而為佳。As said alicyclic epoxy compound, the compound etc. which were described in international publication 2019/138953 are mentioned, for example. Examples of commercially available alicyclic epoxy compounds include UVR-6100, UVR-6105, UVR-6110, UVR-6128, UVR-6200 (the above are manufactured by Union Carbide), Ceroxide 2021, and Ceroxide 2021P. , Ceroxide 2081, Ceroxide 2083, Ceroxide 2085, Ceroxide 2000, Ceroxide 3000, Cyclomer A200, Cyclomer M100, Cyclomer M101, Epolead GT-301, Epolead GT-302, Epolead 401, EpoleadHPE403, ETHB, 30E1 , (shares) made by Daicel), etc. Among alicyclic epoxy compounds, epoxy compounds having a cyclohexene oxide structure are preferred because they harden quickly.
作為上述芳香族環氧化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。作為上述芳香族環氧化合物之市售品,可舉出例如,Denacol EX-146、Denacol EX-147、Denacol EX-201、Denacol EX-203、Denacol EX-711、Denacol EX-721、Oncoat EX-1020、Oncoat EX-1030、Oncoat EX-1040、Oncoat EX-1050、Oncoat EX-1051、Oncoat EX-1010、Oncoat EX-1011、Oncoat 1012(長瀨化學(股)公司製);OGSOLPG-100、OGSOLEG-200、OGSOLEG-210、OGSOLEG-250(大阪氣體化學(股)公司製);HP4032、HP4032D、HP4700(DIC(股)公司製);ESN-475V(日鐵化學&材料(股)公司製);Epikote YX8800(三菱化學(股)公司製);Marproof G-0105SA、Marproof G-0130SP(日油(股)公司製);EpiclonN-665、EpiclonHP-7200(DIC(股)公司製);EOCN-1020、EOCN-102S、EOCN-103S、EOCN-104S、XD-1000、NC-3000、EPPN-501H、EPPN-501HY、EPPN-502H、NC-7000L(日本化藥(股)公司製);Adeka Resin EP-4000、Adeka Resin EP-4005、Adeka Resin EP-4100、Adeka Resin EP-4901((股)ADEKA公司製);或TECHMORE VG-3101L((股)Printec 公司製)等。As said aromatic epoxy compound, the compound etc. which were described in international publication 2019/138953 are mentioned, for example. Examples of commercially available aromatic epoxy compounds include Denacol EX-146, Denacol EX-147, Denacol EX-201, Denacol EX-203, Denacol EX-711, Denacol EX-721, Oncoat EX- 1020, Oncoat EX-1030, Oncoat EX-1040, Oncoat EX-1050, Oncoat EX-1051, Oncoat EX-1010, Oncoat EX-1011, Oncoat 1012 (manufactured by Nagase Chemical Co., Ltd.); OGSOLPG-100, OGSOLEG -200, OGSOLEG-210, OGSOLEG-250 (manufactured by Osaka Gas Chemical Co., Ltd.); HP4032, HP4032D, HP4700 (manufactured by DIC Co., Ltd.); ESN-475V (manufactured by Nippon Steel Chemical & Materials Co., Ltd.) ; Epikote YX8800 (manufactured by Mitsubishi Chemical Corporation); Marproof G-0105SA, Marproof G-0130SP (manufactured by NOF Corporation); EpiclonN-665, EpiclonHP-7200 (manufactured by DIC Corporation); EOCN- 1020, EOCN-102S, EOCN-103S, EOCN-104S, XD-1000, NC-3000, EPPN-501H, EPPN-501HY, EPPN-502H, NC-7000L (Nippon Kayaku Co., Ltd.); Adeka Resin EP-4000, Adeka Resin EP-4005, Adeka Resin EP-4100, Adeka Resin EP-4901 (manufactured by ADEKA Corporation); or TECHMORE VG-3101L (manufactured by Printec Corporation).
作為上述脂肪族環氧化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。作為上述脂肪族環氧化合物之市售品,可舉出例如,Denacol EX-121、Denacol EX-171、Denacol EX-192、Denacol EX-211、Denacol EX-212、Denacol EX-313、Denacol EX-314、Denacol EX-321、Denacol EX-411、Denacol EX-421、Denacol EX-512、Denacol EX-521、Denacol EX-611、Denacol EX-612、Denacol EX-614、Denacol EX-622、Denacol EX-810、Denacol EX-811、Denacol EX-850、Denacol EX-851、Denacol EX-821、Denacol EX-830、Denacol EX-832、Denacol EX-841、Denacol EX-861、Denacol EX-911、Denacol EX-941、Denacol EX-920、Denacol EX-931(長瀨化學(股)公司製);Epolight M-1230、Epolight 40E、Epolight 100E、Epolight 200E、Epolight 400E、Epolight 70P、Epolight 200P、Epolight 400P、Epolight 1500NP、Epolight 1600、Epolight 80MF、Epolight 100MF(共榮社化學(股)公司製)、Adeka Glycyllol ED-503、Adeka Glycyllol ED-503G、Adeka Glycyllol ED-506、Adeka Glycyllol ED-523T、Adeka Resin EP-4088S、或Adeka Resin EP-4080E((股)ADEKA公司製)等。As said aliphatic epoxy compound, the compound etc. which were described in international publication 2019/138953 are mentioned, for example. Examples of commercially available aliphatic epoxy compounds include Denacol EX-121, Denacol EX-171, Denacol EX-192, Denacol EX-211, Denacol EX-212, Denacol EX-313, Denacol EX- 314, Denacol EX-321, Denacol EX-411, Denacol EX-421, Denacol EX-512, Denacol EX-521, Denacol EX-611, Denacol EX-612, Denacol EX-614, Denacol EX-622, Denacol EX- 810, Denacol EX-811, Denacol EX-850, Denacol EX-851, Denacol EX-821, Denacol EX-830, Denacol EX-832, Denacol EX-841, Denacol EX-861, Denacol EX-911, Denacol EX- 941, Denacol EX-920, Denacol EX-931 (manufactured by Nagase Chemical Co., Ltd.); Epolight M-1230, Epolight 40E, Epolight 100E, Epolight 200E, Epolight 400E, Epolight 70P, Epolight 200P, Epolight 400P, Epolight 1500NP , Epolight 1600, Epolight 80MF, Epolight 100MF (manufactured by Kyoeisha Chemical Co., Ltd.), Adeka Glycyllol ED-503, Adeka Glycyllol ED-503G, Adeka Glycyllol ED-506, Adeka Glycyllol ED-523T, Adeka Resin EP-4088S , or Adeka Resin EP-4080E (manufactured by ADEKA Corporation), etc.
又,作為環氧化合物,也可使用賦予有胺基甲酸酯骨架之胺基甲酸酯變性環氧化合物。胺基甲酸酯變性環氧化合物為在分子內具有環氧基與胺基甲酸酯鍵者,例如,可藉由使分子內具有羥基之環氧化合物,與具有異氰酸酯基之化合物進行反應來取得。In addition, as the epoxy compound, a urethane-modified epoxy compound provided with a urethane skeleton can also be used. The urethane-modified epoxy compound has an epoxy group and a urethane bond in the molecule, for example, by reacting an epoxy compound having a hydroxyl group in the molecule with a compound having an isocyanate group. obtain.
又,本發明之硬化性組成物在包含具有式(1)中之作用基為環氧基、環氧丙烷基或環硫化物基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,在不對本發明效果產生不良影響之範圍亦可更含有具有不飽和烴基之化合物等之單體作為其他單體。In addition, the curable composition of the present invention contains a compound having a polymerizable functional group with 1 to 50 carbon atoms whose active group in formula (1) is an epoxy group, a propylene oxide group, or an episulfide group as a curable compound. In the case of non-reactive monomers, monomers such as compounds having unsaturated hydrocarbon groups may be further contained as other monomers within the range that does not adversely affect the effects of the present invention.
上述具有不飽和烴基之化合物只要係作為能與乙烯基、丙烯醯基或甲基丙烯醯基共聚合之化合物而公知之一般使用之化合物,即無特別限制皆可使用。可舉出例如,具有乙烯基之化合物、具有烯丙基之化合物、丙烯酸酯化合物或甲基丙烯酸酯化合物等。The above-mentioned compound having an unsaturated hydrocarbon group can be used without particular limitation as long as it is a known and generally used compound capable of copolymerizing with a vinyl group, an acryl group or a methacryl group. For example, a compound which has a vinyl group, a compound which has an allyl group, an acrylate compound, or a methacrylate compound etc. are mentioned.
作為上述具有乙烯基之化合物及具有烯丙基之化合物,可舉出例如,國際公開第2020/175321號記載之化合物等。As a compound which has the said vinyl group and an allyl group, the compound etc. which are described in international publication 2020/175321 are mentioned, for example.
作為上述丙烯酸酯化合物,可舉出例如,單官能丙烯酸酯化合物、二官能丙烯酸酯化合物或三官能以上之多官能丙烯酸酯化合物。As said acrylate compound, a monofunctional acrylate compound, a difunctional acrylate compound, or a trifunctional or more polyfunctional acrylate compound is mentioned, for example.
作為上述單官能丙烯酸酯化合物、上述二官能丙烯酸酯化合物及上述多官能丙烯酸酯化合物,可舉出例如,國際公開第2020/175321號記載之化合物等。As said monofunctional acrylate compound, said bifunctional acrylate compound, and said polyfunctional acrylate compound, the compound etc. which were described in international publication 2020/175321 are mentioned, for example.
作為上述甲基丙烯酸酯化合物,可舉出例如,單官能甲基丙烯酸酯化合物、二官能甲基丙烯酸酯化合物或三官能以上之多官能甲基丙烯酸酯化合物。As said methacrylate compound, a monofunctional methacrylate compound, a difunctional methacrylate compound, or a trifunctional or more polyfunctional methacrylate compound is mentioned, for example.
作為上述單官能甲基丙烯酸酯化合物、二官能甲基丙烯酸酯化合物或三官能以上之多官能甲基丙烯酸酯化合物,可舉出例如,國際公開第2020/175321號記載之化合物等。Examples of the monofunctional methacrylate compound, difunctional methacrylate compound, or trifunctional or higher polyfunctional methacrylate compound include compounds described in International Publication No. 2020/175321.
本發明之硬化性組成物在包含具有式(1)中之作用基為環氧基、環氧丙烷基或環硫化物基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,從抑制殘留硬化物中之未反應硬化性單體及硬化劑之使用量之觀點,上述硬化劑之摻合量係以相對於硬化性單體1莫耳而成為0.01~2.0莫耳之量為佳。The curable composition of the present invention contains a compound having a polymerizable functional group with 1 to 50 carbon atoms whose functional group in formula (1) is an epoxy group, a propylene oxide group or an episulfide group as a curable unit. In the case of solids, from the viewpoint of suppressing the amount of unreacted hardening monomer and hardening agent in the remaining hardened product, the blending amount of the above hardening agent is 0.01~2.0 moles relative to 1 mole of hardening monomer The amount of ear is better.
本發明之硬化性組成物在包含具有式(1)中之作用基為羥基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含能與羥基反應之公知硬化劑。作為硬化劑,若使用上述環氧化合物、上述潛伏性硬化劑或異氰酸酯化合物時,由於會促進本發明之硬化性組成物之硬化反應而為佳。硬化劑係可使用僅1種,亦可組合使用2種以上。When the curable composition of the present invention contains a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is a hydroxyl group in formula (1) as a curable monomer, it may further contain a compound capable of reacting with a hydroxyl group. Known hardeners. As the curing agent, it is preferable to use the above-mentioned epoxy compound, the above-mentioned latent curing agent, or an isocyanate compound because the curing reaction of the curable composition of the present invention will be accelerated. The curing agent may be used alone or in combination of two or more.
上述硬化劑之異氰酸酯化合物係可舉出例如,n-丁基異氰酸酯、異丙基異氰酸酯、苯基異氰酸酯、苄基異氰酸酯等之單官能異氰酸酯化合物;六亞甲基二異氰酸酯、2,4-甲苯二異氰酸酯、2,6-甲苯二異氰酸酯、1,5-萘二異氰酸酯、二苯基甲烷-4,4’-二異氰酸酯、異佛爾酮二異氰酸酯、二甲苯二異氰酸酯、對苯二異氰酸酯、1,3,6-六亞甲基三異氰酸酯、雙環庚烷三異氰酸酯等之多官能異氰酸酯化合物,或藉由多官能異氰酸酯化合物與三羥甲基丙烷等之活性氫化合物之反應而得之含末端異氰酸酯基之化合物等。從本發明之硬化性組成物之硬化反應變得良好之觀點,摻合於本發明之硬化性組成物之異氰酸酯化合物係以具有複數異氰酸酯基之化合物為佳,以六亞甲基二異氰酸酯、異佛爾酮二異氰酸酯或二甲苯二異氰酸酯為較佳。The isocyanate compounds of the above-mentioned curing agent include, for example, monofunctional isocyanate compounds such as n-butyl isocyanate, isopropyl isocyanate, phenyl isocyanate, and benzyl isocyanate; hexamethylene diisocyanate, 2,4-toluene diisocyanate, Isocyanate, 2,6-toluene diisocyanate, 1,5-naphthalene diisocyanate, diphenylmethane-4,4'-diisocyanate, isophorone diisocyanate, xylene diisocyanate, p-phenylene diisocyanate, 1, Polyfunctional isocyanate compounds such as 3,6-hexamethylene triisocyanate and dicycloheptane triisocyanate, or terminal isocyanate groups obtained by reacting polyfunctional isocyanate compounds with active hydrogen compounds such as trimethylolpropane compounds etc. From the viewpoint that the curing reaction of the curable composition of the present invention becomes favorable, the isocyanate compound blended in the curable composition of the present invention is preferably a compound having multiple isocyanate groups, such as hexamethylene diisocyanate, isocyanate Phorne diisocyanate or xylene diisocyanate is preferred.
本發明之硬化性組成物在包含具有式(1)中之作用基為羥基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含聚醇化合物作為其他單體。When the curable composition of the present invention contains a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is a hydroxyl group in formula (1) as a curable monomer, it may further contain a polyalcohol compound as another monomer.
上述聚醇化合物係表示分子內具有2個以上羥基之化合物,且羥基可為醇性,也可為酚性。具體地可舉出如國際公開第2020/175321號記載之化合物等。The above-mentioned polyalcohol compound refers to a compound having two or more hydroxyl groups in the molecule, and the hydroxyl groups may be alcoholic or phenolic. Specifically, the compound described in International Publication No. 2020/175321, etc. are mentioned.
又,本發明之硬化性組成物在包含具有式(1)中之作用基為羥基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,在不對本發明之效果產生不良影響之範圍,亦可更含有上述具有不飽和烴基之化合物等之硬化性單體作為其他單體。In addition, when the curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is a hydroxyl group in formula (1), it does not affect the effect of the present invention. In the range where adverse effects are produced, curable monomers such as the above-mentioned compounds having unsaturated hydrocarbon groups may be further contained as other monomers.
本發明之硬化性組成物在包含具有式(1)中之作用基為羥基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,從抑制殘留於硬化物中之未反應硬化性單體及硬化劑之使用量之觀點,上述硬化劑之摻合量係以相對於硬化性單體所含之羥基1莫耳而成為0.5~2.0莫耳之量為佳,以成為當量之量為較佳。When the curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is a hydroxyl group in formula (1), it is possible to suppress the remaining in the cured product. From the viewpoint of the usage amount of the unreacted hardening monomer and the hardening agent, the blending amount of the above hardening agent is preferably 0.5~2.0 moles relative to 1 mole of the hydroxyl group contained in the hardening monomer. The equivalent amount is preferable.
本發明之硬化性組成物在包含具有式(1)中之作用基為異氰酸酯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含能與異氰酸酯基反應之公知之硬化劑。作為硬化劑,若使用上述酚化合物或上述環氧化合物,由於會促進本發明之硬化性組成物之硬化反應而為佳。硬化劑係可使用僅1種,亦可組合使用2種以上。When the curable composition of the present invention contains a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is an isocyanate group in formula (1) as a curable monomer, it may further contain Reactive known hardener. As the curing agent, it is preferable to use the above-mentioned phenolic compound or the above-mentioned epoxy compound because the curing reaction of the curable composition of the present invention is accelerated. The curing agent may be used alone or in combination of two or more.
本發明之硬化性組成物在包含具有式(1)中之作用基為異氰酸酯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,在不對本發明效果產生不良影響之範圍,亦可更含有上述具有不飽和烴基之化合物等之硬化性單體作為其他單體。When the curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is an isocyanate group in formula (1), it does not adversely affect the effect of the present invention. The range of influence may further contain curable monomers such as the above-mentioned compounds having unsaturated hydrocarbon groups as other monomers.
本發明之硬化性組成物在包含具有式(1)中之作用基為異氰酸酯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,從抑制殘留於硬化物中之未反應硬化性單體及硬化劑之使用量之觀點,上述硬化劑之摻合量係以相對於硬化性單體能與硬化劑反應之官能基1莫耳而成為0.5~1.5莫耳之量為佳,以成為當量之量為較佳。When the curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is an isocyanate group in the formula (1), it is suppressed from remaining in the cured product. From the viewpoint of the usage amount of the unreacted hardening monomer and the hardener, the blending amount of the above-mentioned hardening agent is 0.5~1.5 mol relative to 1 mol of the functional group of the hardening monomer that can react with the hardening agent. The amount is preferred, and the equivalent amount is preferred.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、丙烯醯基或甲基丙烯醯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含公知之聚合起始劑作為能與本發明之化合物反應而形成硬化物的成分。作為聚合起始劑,可舉出如,自由基聚合起始劑、陽離子聚合起始劑等。聚合起始劑係可使用僅1種,亦可組合使用2種以上。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group with 1 to 50 carbon atoms in which the active group in formula (1) is vinyl, acryl or methacryl. In some cases, a known polymerization initiator may be further included as a component capable of reacting with the compound of the present invention to form a cured product. As a polymerization initiator, a radical polymerization initiator, a cationic polymerization initiator, etc. are mentioned, for example. The polymerization initiator may be used alone or in combination of two or more.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、丙烯醯基或甲基丙烯醯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,從使硬化性組成物之聚合反應良好地進行且使反應後之硬化物之物性提升的觀點,聚合起始劑之摻合量係以相對於硬化性組成物為0.001質量%~20質量%為佳,以0.1質量%~10質量%為較佳。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group with 1 to 50 carbon atoms in which the active group in formula (1) is vinyl, acryl or methacryl. In this case, from the viewpoint of making the polymerization reaction of the curable composition progress well and improving the physical properties of the cured product after the reaction, the blending amount of the polymerization initiator is 0.001% by mass to 20% by mass relative to the curable composition. % by mass is preferable, more preferably 0.1% by mass to 10% by mass.
作為上述自由基聚合起始劑,可舉出如,光自由基聚合起始劑或熱自由基聚合起始劑。As said radical polymerization initiator, a photo radical polymerization initiator or a thermal radical polymerization initiator is mentioned, for example.
作為上述光自由基聚合起始劑,可舉出如,苯乙酮系化合物、苄基系化合物、二苯甲酮系化合物、噻噸酮系化合物、聯咪唑(bisimidazole)系化合物、吖啶系化合物、醯基膦系化合物或肟酯化合物等。Examples of the photoradical polymerization initiator include acetophenone-based compounds, benzyl-based compounds, benzophenone-based compounds, thioxanthone-based compounds, bisimidazole-based compounds, acridine-based compounds, acyl phosphine compounds or oxime ester compounds, etc.
作為上述苯乙酮系化合物,可舉出例如,國際公開第2016/098471號記載之化合物等。As said acetophenone compound, the compound etc. which are described in international publication 2016/098471 are mentioned, for example.
作為上述苄基系化合物,可舉出例如,國際公開第2016/098471號記載之化合物等。As said benzyl type compound, the compound etc. which are described in international publication 2016/098471 are mentioned, for example.
作為上述二苯甲酮系化合物,可舉出例如,國際公開第2016/098471號記載之化合物等。As said benzophenone compound, the compound etc. which are described in international publication 2016/098471 are mentioned, for example.
作為上述噻噸酮系化合物,可舉出例如,國際公開第2016/098471號記載之化合物等。As said thioxanthone compound, the compound etc. which are described in international publication 2016/098471 are mentioned, for example.
作為上述聯咪唑系化合物,可舉出例如,國際公開第2019/138953號或國際公開第00/52529號記載之化合物等。Examples of the biimidazole-based compound include compounds described in International Publication No. 2019/138953 or International Publication No. 00/52529.
作為上述吖啶系化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。Examples of the acridine-based compound include compounds described in International Publication No. 2019/138953.
作為上述醯基膦系化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。Examples of the above-mentioned acylphosphine compounds include compounds described in International Publication No. 2019/138953, and the like.
作為上述肟酯化合物,可舉出例如,國際公開第2019/138953號記載之化合物等。As said oxime ester compound, the compound etc. which were described in international publication 2019/138953 are mentioned, for example.
作為上述熱自由基聚合起始劑,可舉出例如,國際公開第2019/138953號記載之化合物等。As said thermal radical polymerization initiator, the compound etc. which were described in international publication 2019/138953 are mentioned, for example.
作為上述陽離子聚合起始劑,只要係因照射能量線或加熱而能釋放起始陽離子聚合之物質之化合物,任何化合物皆無妨,以因照射能量線而會釋放路易斯酸之鎓鹽之複鹽、或其衍生物為佳。As the above-mentioned cationic polymerization initiator, any compound may be used as long as it is a compound that releases a substance that initiates cationic polymerization by irradiation with energy rays or heating. Double salts of onium salts that release Lewis acids by irradiation with energy rays, or its derivatives are preferred.
作為鎓鹽,可舉出例如,[M] r+[G] r-所示之陽離子與陰離子之鹽。 在此陽離子[M] r+係以鎓陽離子為佳,其構造能以例如,式[(R 9)fQ] r+來表示。 Examples of the onium salt include salts of cations and anions represented by [M] r+ [G] r- . Here, the cation [M] r+ is preferably an onium cation, and its structure can be represented by, for example, the formula [(R 9 )fQ] r+ .
R 9為碳原子數1~60,可包含數個碳原子以外之原子之有機基。f為1~5之整數。f個之R 9可為相同,亦可為相異。又,f個之R 13之至少1個係以具有芳香環之有機基為佳。Q為選自由S、N、Se、Te、P、As、Sb、Bi、O、I、Br、Cl、F及N=N所成群之原子或原子團。又,將陽離子[M] r+中之Q之原子價設為q時,必須會成立r=f-q之關係(但,N=N操作作為原子價0)。 R 9 is an organic group with 1 to 60 carbon atoms that may contain several atoms other than carbon atoms. f is an integer from 1 to 5. The f R 9 may be the same or different. Also, at least one of the f R 13 is preferably an organic group having an aromatic ring. Q is an atom or an atom group selected from the group consisting of S, N, Se, Te, P, As, Sb, Bi, O, I, Br, Cl, F and N=N. Also, when the atomic valence of Q in the cation [M] r+ is set to q, the relationship of r=fq must be established (however, N=N is operated as atomic valence 0).
又,作為陰離子[G] r-之具體例,作為一價者,可舉出如,氯化物離子、溴化物離子、碘化物離子、氟化物離子等之鹵化物離子;過氯酸離子、氯酸離子、硫氰酸離子、六氟磷酸離子、六氟銻酸離子、四氟硼酸離子等之無機系陰離子;肆(五氟苯基)硼酸根、四(3,5-二氟-4-甲氧基苯基)硼酸根、四氟硼酸根、四芳基硼酸根、肆(五氟苯基)硼酸根等之硼酸根系陰離子;甲烷磺酸離子、十二基磺酸離子、苯磺酸離子、甲苯磺酸離子、三氟甲烷磺酸離子、萘磺酸離子、二苯基胺-4-磺酸離子、2-胺基-4-甲基-5-氯苯磺酸離子、2-胺基-5-硝基苯磺酸離子、酞花青磺酸離子、氟磺酸離子、三硝基苯磺酸陰離子、樟腦磺酸離子、九氟丁烷磺酸離子、十六氟辛烷磺酸離子、具有聚合性取代基之磺酸離子、日本特開平10-235999號公報、日本特開平10-337959號公報、日本特開平11-102088號公報、日本特開2000-108510號公報、日本特開2000-168223號公報、日本特開2001-209969號公報、日本特開2001-322354號公報、日本特開2006-248180號公報、日本特開2006-297907號公報、日本特開平8-253705號公報、日本特表2004-503379號公報、日本特開2005-336150號公報、國際公開第2006/28006號等記載之磺酸離子等之有機磺酸系陰離子;辛基磷酸離子、十二基磷酸離子、十八基磷酸離子、苯基磷酸離子、壬基苯基磷酸離子、2,2’-亞甲基雙(4,6-二-tert-丁基苯基)膦酸離子等之有機磷酸系陰離子、雙三氟甲基磺醯基醯亞胺離子、雙全氟丁烷磺醯基醯亞胺離子、全氟-4-乙基環己烷磺酸離子、肆(五氟苯基)硼酸離子或參(氟烷基磺醯基)碳陰離子等,作為二價者,可舉出例如,苯二磺酸離子、萘二磺酸離子等。 Also, as a specific example of the anion [G] r- , as a monovalent one, halide ions such as chloride ion, bromide ion, iodide ion, fluoride ion, etc.; perchlorate ion, chlorine Inorganic anions such as acid ion, thiocyanate ion, hexafluorophosphate ion, hexafluoroantimonate ion, tetrafluoroborate ion, etc.; tetrakis (pentafluorophenyl) borate, tetrakis (3,5-difluoro-4- Methoxyphenyl) borate, tetrafluoroborate, tetraaryl borate, tetrakis (pentafluorophenyl) borate and other borate anions; methanesulfonate ion, dodecylsulfonate ion, benzenesulfonic acid Ion, toluenesulfonate ion, trifluoromethanesulfonate ion, naphthalenesulfonate ion, diphenylamine-4-sulfonate ion, 2-amino-4-methyl-5-chlorobenzenesulfonate ion, 2- Amino-5-nitrobenzenesulfonate ion, phthalocyaninesulfonate ion, fluorosulfonate ion, trinitrobenzenesulfonate anion, camphorsulfonate ion, nonafluorobutanesulfonate ion, hexadecafluorooctane Sulfonate ion, sulfonate ion having a polymerizable substituent, JP-A-10-235999, JP-10-337959, JP-11-102088, JP-2000-108510, JP 2000-168223, JP 2001-209969, JP 2001-322354, JP 2006-248180, JP 2006-297907, JP 8- 253705 Gazette, JP 2004-503379 Gazette, JP 2005-336150 Gazette, International Publication No. 2006/28006 and other organic sulfonic acid anions such as sulfonic acid ions; octyl phosphate ion, dodeca Phosphate ion, octadecyl phosphate ion, phenyl phosphate ion, nonylphenyl phosphate ion, 2,2'-methylene bis(4,6-di-tert-butylphenyl) phosphonic acid ion, etc. Organic phosphoric acid series anion, bistrifluoromethylsulfonyl imide ion, bis perfluorobutanesulfonyl imide ion, perfluoro-4-ethylcyclohexanesulfonate ion, tetrakis (pentafluorophenyl ) borate ion or ginseng(fluoroalkylsulfonyl)carbanion, etc., as divalent ones, for example, benzene disulfonate ion, naphthalene disulfonate ion, etc.
此種鎓鹽之中,若使用芳基重氮鹽、二芳基錪鹽或三芳基鋶鹽等之芳香族鋶鹽,由於本發明之硬化性組成物之聚合反應會變得良好而為佳。Among such onium salts, it is preferable to use aromatic permeic salts such as aryl diazonium salts, diaryl permeic acid salts, or triaryl permeic acid salts, because the polymerization reaction of the hardening composition of the present invention will become good. .
芳香族鋶鹽可使用市售者,可舉出例如,WPAG-336、WPAG-367、WPAG-370、WPAG-469、WPAG-638(和光純藥工業股份有限公司公司製)、CPISO-100P、CPISO-101A、CPISO-200K、CPISO-210S(San-Apro股份有限公司製)、Adeka Arkls SP-056、Adeka Arkls SP-066、Adeka Arkls SP-130、Adeka Arkls SP-140、Adeka Arkls SP-082、Adeka Arkls SP-103、Adeka Arkls SP-601、Adeka Arkls SP-606、Adeka Arkls SP-701、Adeka Arkls SP-150、Adeka Arkls SP-170(股份有限公司ADEKA製)等。Aromatic permeicium salts can be commercially available, for example, WPAG-336, WPAG-367, WPAG-370, WPAG-469, WPAG-638 (manufactured by Wako Pure Chemical Industries, Ltd.), CPISO-100P, CPISO-101A, CPISO-200K, CPISO-210S (manufactured by San-Apro Co., Ltd.), Adeka Arkls SP-056, Adeka Arkls SP-066, Adeka Arkls SP-130, Adeka Arkls SP-140, Adeka Arkls SP-082 , Adeka Arkls SP-103, Adeka Arkls SP-601, Adeka Arkls SP-606, Adeka Arkls SP-701, Adeka Arkls SP-150, Adeka Arkls SP-170 (manufactured by ADEKA Co., Ltd.), etc.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、丙烯醯基或甲基丙烯醯基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,在不對本發明效果產生不良影響之範圍,亦可更含有上述環氧化合物、上述聚醇化合物、上述具有不飽和烴基之化合物等之硬化性單體作為其他單體。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group with 1 to 50 carbon atoms in which the active group in formula (1) is vinyl, acryl or methacryl. In some cases, curable monomers such as the above-mentioned epoxy compound, the above-mentioned polyalcohol compound, and the above-mentioned compound having an unsaturated hydrocarbon group may be further contained as other monomers within the range that does not adversely affect the effect of the present invention.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、環氧基或環氧丙烷基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,可更包含上述陽離子聚合起始劑作為能與本發明之化合物反應而形成硬化物的成分。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is vinyl, epoxy or propylene oxide in formula (1). In some cases, the above-mentioned cationic polymerization initiator may be further included as a component capable of reacting with the compound of the present invention to form a cured product.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、環氧基或環氧丙烷基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,在不對本發明效果產生不良影響之範圍,亦可更含有上述環氧化合物、上述具有不飽和烴基之化合物等之硬化性單體作為其他單體。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is vinyl, epoxy or propylene oxide in formula (1). In some cases, curable monomers such as the above-mentioned epoxy compound and the above-mentioned compound having an unsaturated hydrocarbon group may be further contained as other monomers within the range that does not adversely affect the effect of the present invention.
本發明之硬化性組成物在包含具有式(1)中之作用基為乙烯基、環氧基或環氧丙烷基之碳原子數1~50之聚合性官能基之化合物作為硬化性單體之情況,從使硬化性組成物之聚合反應良好地進行且使反應後之硬化物之物性提升之觀點,上述陽離子聚合起始劑之摻合量係以相對於硬化性組成物為0.001質量%~20質量%為佳,以0.1質量%~10質量%為較佳。The curable composition of the present invention contains, as a curable monomer, a compound having a polymerizable functional group having 1 to 50 carbon atoms whose functional group is vinyl, epoxy or propylene oxide in formula (1). In some cases, from the standpoint of making the polymerization reaction of the curable composition proceed well and improving the physical properties of the cured product after the reaction, the blending amount of the above-mentioned cationic polymerization initiator is 0.001% by mass to the curable composition. 20% by mass is preferable, more preferably 0.1% by mass to 10% by mass.
本發明之硬化性組成物中之作為硬化性單體之本發明之化合物及其他單體之摻合量並非係受到特別限定者,可基於硬化物所要求之特性等來適宜調整。從容易維持硬化物之優異自我修復力之觀點,相對於本發明之硬化性組成物,作為硬化性單體之本發明之化合物與其他單體之合計量係以0.01質量%~99.999質量%為佳,以0.05質量%~99.9質量%為較佳,以0.1質量%~97質量%為更佳。The compounding quantity of the compound of this invention which is a curable monomer, and other monomers in the curable composition of this invention is not specifically limited, It can adjust suitably based on the characteristic etc. required for a cured product. From the viewpoint of easy maintenance of the excellent self-healing ability of the cured product, the total amount of the compound of the present invention as a curable monomer and other monomers is 0.01% by mass to 99.999% by mass relative to the curable composition of the present invention. Better, more preferably 0.05% by mass to 99.9% by mass, more preferably 0.1% by mass to 97% by mass.
又,本發明之硬化性組成物可包含作為本發明之化合物作為硬化劑。作為硬化劑之本發明之化合物係可舉出如具有選自由乙烯基、丙烯醯基、甲基丙烯醯基、羥基、異氰酸酯基、胺基、醯胺基、環氧基、環氧丙烷基、環硫化物基、羧基、雜芳基、巰基、包含羧酸酐構造之基及包含環狀醯亞胺構造之基所成群之作用基之式(1)所示之化合物。Also, the curable composition of the present invention may contain the compound of the present invention as a curing agent. The compound of the present invention as a curing agent can include, for example, a compound having a compound selected from vinyl, acryl, methacryl, hydroxyl, isocyanate, amine, amide, epoxy, epoxypropylene, A compound represented by the formula (1) of an episulfide group, a carboxyl group, a heteroaryl group, a mercapto group, a group including a group having a carboxylic anhydride structure, and a group including a cyclic imide structure.
尚且,使用本發明之化合物作為硬化劑之情況,上述本發明之硬化性組成物中之硬化劑之摻合量則為本發明之化合物與公知硬化劑之合計量。Furthermore, when the compound of the present invention is used as a curing agent, the amount of the curing agent blended in the above-mentioned curable composition of the present invention is the total amount of the compound of the present invention and known curing agents.
本發明之硬化性組成物可更包含高分子化合物、環氧硬化物、胺基甲酸酯硬化物或橡膠成分。The curable composition of the present invention may further include polymer compound, epoxy cured product, urethane cured product or rubber component.
作為能使用於本發明之硬化性組成物中之高分子化合物,可使用以往公知高分子化合物當中之高分子化合物,可舉出例如,國際公開第2020/175321號記載之高分子化合物等。As the polymer compound that can be used in the curable composition of the present invention, conventionally known polymer compounds can be used, for example, polymer compounds described in International Publication No. 2020/175321 and the like.
作為能使用於本發明之硬化性組成物中之環氧硬化物,可舉出如,使以往公知之環氧樹脂經硬化者。Examples of cured epoxy resins that can be used in the curable composition of the present invention include cured epoxy resins that have been conventionally known.
作為能使用於本發明之硬化性組成物中之胺基甲酸酯硬化物,可舉出如,使以往公知之胺基甲酸酯樹脂經硬化者。Examples of cured urethane resins that can be used in the curable composition of the present invention include cured conventionally known urethane resins.
作為能使用於本發明之硬化性組成物中之橡膠成分,可使用以往公知之橡膠成分,可舉出例如,國際公開第2020/175321號記載之橡膠成分等。As the rubber component that can be used in the curable composition of the present invention, conventionally known rubber components can be used, for example, rubber components described in International Publication No. 2020/175321 and the like.
本發明之硬化性組成物為了均勻混合材料,或為了確保本發明之硬化性組成物之良好成形性、良好製膜性,亦可含有有機溶劑作為稀釋劑。有機溶劑並非係該當於本發明之化合物、其他單體、硬化劑或聚合起始劑者,且係表示在25℃、大氣壓下為液狀者。The curable composition of the present invention may also contain an organic solvent as a diluent in order to uniformly mix materials, or to ensure good formability and film forming properties of the curable composition of the present invention. The organic solvent is not the compound, other monomers, hardeners or polymerization initiators of the present invention, and is liquid at 25°C and atmospheric pressure.
作為能使用於本發明之硬化性組成物中之有機溶劑,可舉出例如,醇系溶劑、酮系溶劑、醯胺系溶劑、醚系溶劑、酯系溶劑、脂肪族烴系溶劑、芳香族系溶劑或含鹵素溶劑等。Examples of organic solvents that can be used in the curable composition of the present invention include alcohol-based solvents, ketone-based solvents, amide-based solvents, ether-based solvents, ester-based solvents, aliphatic hydrocarbon-based solvents, aromatic solvents or halogen-containing solvents, etc.
作為醇系溶劑,可舉出例如,國際公開第2020/175321號記載之醇系溶劑等。該等醇系溶劑係可使用僅1種,亦可組合使用2種以上。As an alcoholic solvent, the alcoholic solvent etc. which were described in international publication 2020/175321 are mentioned, for example. These alcohol-based solvents may be used alone or in combination of two or more.
作為酮系溶劑,可舉出例如,國際公開第2020/175321號記載之酮系溶劑等。該等酮系溶劑係可使用僅1種,亦可組合使用2種以上。As a ketone-type solvent, the ketone-type solvent etc. which are described in international publication 2020/175321 are mentioned, for example. These ketone-based solvents may be used alone or in combination of two or more.
作為醯胺系溶劑,可舉出例如,國際公開第2020/175321號記載之醯胺系溶劑等。該等醯胺系溶劑係可使用僅1種,亦可組合使用2種以上。Examples of the amide-based solvent include amide-based solvents described in International Publication No. 2020/175321. These amide-based solvents may be used alone or in combination of two or more.
作為醚溶劑系,可舉出例如,國際公開第2020/175321號記載之醚系溶劑等。該等醚系溶劑係可使用僅1種,亦可組合使用2種以上。Examples of ether solvents include ether solvents described in International Publication No. 2020/175321. These ether-based solvents may be used alone or in combination of two or more.
作為酯系溶劑,可舉出例如,國際公開第2020/175321號記載之酯系溶劑等。該等酯系溶劑係可使用僅1種,亦可組合使用2種以上。As an ester type solvent, the ester type solvent etc. which were described in international publication 2020/175321 are mentioned, for example. These ester-based solvents may be used alone or in combination of two or more.
作為脂肪族烴系溶劑,可舉出例如,國際公開第2020/175321號記載之脂肪族烴系溶劑等。該等脂肪族烴系溶劑係可使用僅1種,亦可組合使用2種以上。As an aliphatic hydrocarbon solvent, the aliphatic hydrocarbon solvent etc. which are described in international publication 2020/175321 are mentioned, for example. These aliphatic hydrocarbon-based solvents may be used alone or in combination of two or more.
作為芳香族烴系溶劑,可舉出例如,國際公開第2020/175321號記載之芳香族烴系溶劑等。該等芳香族烴系溶劑係可使用僅1種,亦可組合使用2種以上。As an aromatic hydrocarbon solvent, the aromatic hydrocarbon solvent etc. which are described in international publication 2020/175321 are mentioned, for example. These aromatic hydrocarbon solvents may be used alone or in combination of two or more.
作為含鹵素溶劑,可舉出例如,國際公開第2020/175321號記載之含鹵素溶劑等。該等含鹵素溶劑係可使用僅1種,亦可組合使用2種以上。As a halogen-containing solvent, the halogen-containing solvent of International Publication No. 2020/175321, etc. are mentioned, for example. These halogen-containing solvents may be used alone or in combination of two or more.
本發明之硬化性組成物中,上述有機溶劑係可使用僅1種,亦可組合使用2種以上。該等有機溶劑之種類或摻合量係可因應硬化性組成物之黏度、進行成形之形狀等來適宜選定。從本發明之硬化性組成物之操作容易度之觀點,相對於本發明之硬化性組成物,有機溶劑之摻合量係以0.1質量%~90質量%為佳,以0.5質量%~80質量%為較佳,以10質量%~70質量%為更佳。In the curable composition of the present invention, the above-mentioned organic solvents may be used alone or in combination of two or more. The type or blending amount of these organic solvents can be appropriately selected according to the viscosity of the curable composition, the shape to be molded, and the like. From the viewpoint of the ease of handling of the curable composition of the present invention, relative to the curable composition of the present invention, the blending amount of the organic solvent is preferably 0.1% by mass to 90% by mass, and preferably 0.5% by mass to 80% by mass. % is better, more preferably 10% by mass to 70% by mass.
又,只要不損及本發明之效果,因應必要也可將紫外線吸收劑、光安定劑、接著助劑、聚合禁止劑、增感劑、防氧化劑、平滑性賦予劑、配向控制劑、紅外線吸收劑、觸變劑、防帶電劑、消泡劑、著色劑、乳化劑、界面活性劑、導電性賦予劑、水解抑制劑、纖維素奈米纖維、聚合觸媒或填料等之填充劑等之公知添加劑,以公知之含量,公知之使用方法來摻合於本發明之硬化性組成物中。In addition, as long as the effects of the present invention are not impaired, ultraviolet absorbers, light stabilizers, adhesive additives, polymerization inhibitors, sensitizers, antioxidants, smoothness imparting agents, alignment control agents, infrared absorbers, etc. agent, thixotropic agent, antistatic agent, defoamer, colorant, emulsifier, surfactant, conductivity imparting agent, hydrolysis inhibitor, cellulose nanofiber, polymerization catalyst or filler, etc. Known additives are blended into the curable composition of the present invention at known contents and using methods.
作為本發明之硬化性組成物之用途,並無特別限定,可適宜使用作為自我修復材料。自我修復材料係指在材料之使用環境下,受到刮擦、打撃等而產生擦傷或損傷之際,無外部之刺激,或藉由特定之操作或處理、外部刺激,而能自我修復擦傷或損傷的材料。來自外部之刺激係指接觸、光照射、加熱或加壓等,該等係可單獨來賦予,亦可依序或同時地賦予2種以上之外部刺激。The use of the curable composition of the present invention is not particularly limited, and it can be suitably used as a self-healing material. Self-healing materials refer to materials that can self-repair scratches or damages without external stimuli, or through specific operations or treatments or external stimuli, when they are scratched or damaged by scratches or blows in the environment in which they are used. s material. External stimuli refer to contact, light irradiation, heat or pressure, etc., and these may be given alone, or two or more kinds of external stimuli may be given sequentially or simultaneously.
本發明之硬化性組成物係也可使用作為表面塗覆劑、塗料、接著劑或電池用材料。表面塗覆劑係在以保護基材表面、對基材賦予設計性或光學特性、控制表面物性、對基材賦予防污染性、耐藥品性或耐氣候性等之目的來使用者。作為將本發明之硬化性組成物塗佈於基材表面之方法,以公知方法來實施即可,可舉出例如,模具塗佈(die coating)法、逗點式塗佈(comma coating)法、簾式塗佈法、噴霧塗佈法、凹版塗佈法、柔版塗佈法、刀塗(knife coating)法、刮刀塗佈(doctor blade coating)法、反向輥法、刷塗法、浸漬法、噴墨法或線棒塗佈法等。將本發明之硬化性組成物使用作為表面塗覆劑之情況,將硬化前之組成物塗佈於基材表面,其後以後述之方法使其硬化即可。將本發明之硬化性組成物使用作為表面塗覆劑、塗料、接著劑或電池用材料之情況,也可摻合表面塗覆劑、塗料、接著劑或電池用材料等所使用之公知之添加劑。The curable composition system of the present invention can also be used as a surface coating agent, paint, adhesive or battery material. Surface coating agents are used for the purpose of protecting the surface of a substrate, imparting design or optical properties to a substrate, controlling surface physical properties, and imparting anti-pollution, chemical resistance, or weather resistance to a substrate. As a method for coating the curable composition of the present invention on the substrate surface, it may be carried out by known methods, for example, die coating (die coating) method, comma coating (comma coating) method , curtain coating method, spray coating method, gravure coating method, flexo coating method, knife coating (knife coating) method, doctor blade coating (doctor blade coating) method, reverse roll method, brush coating method, Dipping method, inkjet method or wire bar coating method, etc. When using the curable composition of the present invention as a surface coating agent, it is sufficient to apply the composition before hardening to the surface of the substrate, and then harden it by the method described later. When the curable composition of the present invention is used as a surface coating agent, paint, adhesive, or battery material, known additives used in surface coating agents, paints, adhesives, or battery materials can also be blended. .
<硬化物> 其次,說明關於本發明之硬化物。 本發明之硬化物係使上述之硬化性組成物進行硬化而得者。本發明之硬化物並非係受到硬度、物性等所限定者。 <hardened material> Next, the cured product of the present invention will be described. The cured product of the present invention is obtained by curing the above curable composition. The hardened product of the present invention is not limited by hardness, physical properties, and the like.
作為使上述硬化性組成物硬化之方法,例如,將上述硬化性組成物塗佈於基材後,或使上述硬化性組成物成形後,藉由照射能量線或加熱而可取得本發明之硬化物。照射能量線及加熱係可實施任一者,可個別交替地實施,可同時地實施,亦可經時性地使其變化並同時來實施。As a method of curing the above-mentioned curable composition, for example, after applying the above-mentioned curable composition to a substrate, or after molding the above-mentioned curable composition, the curing of the present invention can be obtained by irradiating energy rays or heating. thing. Irradiation of energy rays and heating may be performed either, may be performed individually and alternately, may be performed simultaneously, or may be performed while changing over time.
本發明之硬化性組成物在藉由照射能量線使其硬化之情況,作為能量線,可舉出如紫外線、電子線、X射線、放射線、高頻等,從經濟性觀點,以紫外線為佳。作為紫外線之光源,可舉出例如,水銀燈、氙氣燈、碳弧燈、金屬鹵素燈、太陽光、雷射光源或LED光源等。光源係因應被任意添加於本發明之硬化性組成物中之光自由基起始劑來適宜選擇即可,在操作性之面上,以UV-LED(波長:350~450nm)為佳。累積照射量係根據對象物之厚度來適宜變更即可,在累積照射量不充分之情況,硬化反應會無法充分進行,累積照射量若過大時,則會有對象物著色的情況。從變得容易控制硬化反應之觀點,累積照射量係以1mJ/cm 2~100,000mJ/cm 2之範圍為佳。 When the curable composition of the present invention is cured by irradiating energy rays, examples of energy rays include ultraviolet rays, electron rays, X-rays, radiation rays, high frequency, etc., and ultraviolet rays are preferable from an economic point of view. . As a light source of ultraviolet light, a mercury lamp, a xenon lamp, a carbon arc lamp, a metal halide lamp, sunlight, a laser light source, or an LED light source etc. are mentioned, for example. The light source can be properly selected according to the photo-radical initiator optionally added to the curable composition of the present invention. In terms of operability, UV-LED (wavelength: 350~450nm) is preferred. The cumulative exposure dose can be appropriately changed according to the thickness of the object. If the cumulative exposure dose is insufficient, the curing reaction will not proceed sufficiently. If the cumulative exposure dose is too large, the object may be colored. From the viewpoint of making it easier to control the curing reaction, the cumulative exposure dose is preferably in the range of 1 mJ/cm 2 to 100,000 mJ/cm 2 .
藉由加熱來使本發明之硬化性組成物硬化之情況,從變得容易控制硬化反應之觀點,加熱係以作成200℃以下為佳,以作成140℃以下為較佳。又,從能良好地進行硬化反應之觀點,加熱係以作成40℃以上為佳,以作成50℃以上為較佳。加熱時係因應加熱溫度等來適宜選擇即可,以1秒~20小時為佳,以10秒~10小時為較佳。When the curable composition of the present invention is cured by heating, the heating is preferably 200°C or lower, more preferably 140°C or lower, from the viewpoint of easy control of the curing reaction. In addition, from the viewpoint that the curing reaction can proceed favorably, the heating system is preferably at least 40°C, more preferably at least 50°C. The heating can be appropriately selected according to the heating temperature, etc., preferably 1 second to 20 hours, and more preferably 10 seconds to 10 hours.
在製造硬化物時之壓力通常係能在大氣壓進行,也可在1,000氣壓以下之條件下施加壓力來進行。製造硬化物時之環境係因應硬化性組成物之組成等來選擇適宜環境即可,可在大氣環境下,也可在氮氣、氬氣等之惰性氣體環境下。The pressure in the production of hardened products can usually be carried out at atmospheric pressure, and it can also be carried out by applying pressure under the condition of 1,000 atmospheric pressure. The environment for manufacturing the cured product can be selected according to the composition of the curable composition, etc., and can be in the atmosphere or in an inert gas environment such as nitrogen or argon.
本發明之硬化物也可不使用有機溶劑而使硬化性組成物成形、硬化來製造,亦可使用有機溶劑,調整硬化性組成物之黏度等後使其成形、硬化來製造。又,也可使用溶劑來使已製造之硬化物溶解或膨潤,而進行成形、製膜。又,也可藉由水系之乳化聚合、或懸浮聚合,在水中乳化、或經分散之狀態下來製造硬化物。The cured product of the present invention may be produced by molding and curing a curable composition without using an organic solvent, or may be produced by molding and curing the curable composition after adjusting the viscosity of the curable composition using an organic solvent. In addition, a solvent may be used to dissolve or swell the produced cured product to perform molding and film formation. Moreover, it is also possible to produce a cured product in a state of being emulsified or dispersed in water by aqueous emulsion polymerization or suspension polymerization.
作為本發明之硬化物之用途,可適宜使用於例如,密封材、隔熱材、防音材、塗覆劑、衛生材料、軟管夾、流體輸送用管、軟管、熱熔接著劑、接著劑用添加劑、光學材料、電子機器、電池材料、車輛、船舶、航空機、建築物、住宅及建築用材料、土木材料、衣料、簾幕、被單、容器、眼鏡、包殼或運動用品等必須要有耐斷裂性或耐疲勞性之用途上。As the use of the hardened product of the present invention, it can be suitably used, for example, in sealing materials, heat insulating materials, soundproofing materials, coating agents, sanitary materials, hose clamps, fluid conveying pipes, hoses, hot-melt adhesives, adhesives, etc. Additives for pharmaceuticals, optical materials, electronic equipment, battery materials, vehicles, ships, aircraft, buildings, housing and construction materials, civil engineering materials, clothing materials, curtains, sheets, containers, glasses, casings or sporting goods, etc. For applications with fracture resistance or fatigue resistance.
作為更具體之用途,可舉出如,光學薄膜、光學薄片、光學過濾器、高亮度稜鏡薄片、光學集光器、防眩薄膜等之防反射材料、照明器具、透明採光材料、保護薄膜、筆輸入裝置用表面材料、電纜、護套、電線被覆材、電絕緣用構件、電子機器框體、機械零件、耐振動疲勞構件、電容器、二次電池用隔件、二次電池用黏合劑、固體電解質、纖維強化材料、防鏽劑、防腐食材料、噴塗顏料、阻隔材料(有機物、氣體、濕度)等之塗料、寵物用建材、地板、壁、門等之建材、遮水薄片、防水薄片、致動器、清潔墊、浴缸、盆、桶、入浴輔助品、汽車材料、人工皮革、合成皮革、人工皮膚、血管內治療用支架、牙科用複合修復材料、套筒材料、層合玻璃、轉印箔、難燃性薄膜、文具用軸筒、緩衝材料、緩衝劑、農業用薄膜、加飾薄膜、化妝薄片、溫室用薄片、防蟲網、家具、衣服、包、鞋、護目鏡、滑雪雙板(ski board)、滑雪單板(snowboard)、球拍、帳篷、容器、砧板、切板、抗菌薄膜、抗菌成形體、阻隔薄膜或襯墊等。More specific applications include anti-reflection materials such as optical films, optical sheets, optical filters, high-brightness flakes, optical concentrators, anti-glare films, lighting fixtures, transparent lighting materials, and protective films. , Surface materials for pen input devices, cables, sheaths, wire covering materials, electrical insulation members, electronic equipment housings, mechanical parts, vibration fatigue-resistant members, capacitors, separators for secondary batteries, adhesives for secondary batteries , solid electrolyte, fiber reinforced material, anti-rust agent, anti-food material, spray paint, coating for barrier materials (organic matter, gas, humidity), etc., building materials for pets, building materials for floors, walls, doors, etc., water-shielding sheets, waterproofing Sheets, actuators, cleaning pads, bathtubs, basins, buckets, bathing aids, automotive materials, artificial leather, synthetic leather, artificial skin, stents for endovascular therapy, composite restoration materials for dentistry, sleeve materials, laminated glass , transfer foil, flame retardant film, stationery shaft, cushioning material, cushioning agent, agricultural film, decorative film, cosmetic sheet, greenhouse sheet, insect net, furniture, clothes, bags, shoes, goggles , ski board, snowboard, racket, tent, container, chopping board, cutting board, antibacterial film, antibacterial molded body, barrier film or liner, etc.
將本發明之硬化性組成物適用於表面塗覆劑時,具有改善因塗覆所產生之加工不良的效果,例如可藉由使用作為模內成型用硬塗覆材料來提升成型加工時之加工性。When the curable composition of the present invention is applied to a surface coating agent, it has the effect of improving the poor processing caused by coating. For example, the processing during molding can be improved by using it as a hard coating material for in-mold molding. sex.
將本發明之硬化性組成物適用於塗料時,可取得會自我修復塗膜損傷之效果。例如在使用作為汽車用塗料之情況,由於僅靠加熱就能修復塗裝之損傷,故變得不需要重新塗裝。When the curable composition of the present invention is applied to paint, it can achieve the effect of self-healing the damage of the paint film. For example, when it is used as a paint for automobiles, since the damage of the paint can be repaired only by heating, it becomes unnecessary to repaint.
將本發明之硬化性組成物適用於接著劑時,可取得接著後之硬化物在裁切後會自發性接合的效果,而可抑制接著不良或因劣化所造成之剝離。又,可賦予應力緩和後之硬化,而變得能提升接著強度。When the curable composition of the present invention is used as an adhesive, the cured product after bonding can be spontaneously bonded after cutting, and peeling due to poor bonding or deterioration can be suppressed. In addition, hardening after stress relaxation can be imparted, and adhesive strength can be improved.
將本發明之硬化性組成物適用於電池用材料時,可取得斷裂後自我修復的效果。例如,在重複使用二次電池之充放電之際,會有電極膨脹而黏合劑斷裂的情況,但即使斷裂黏合劑仍會自我修復而防止電極分解,進而能防止電池性能劣化。When the curable composition of the present invention is used as a battery material, the effect of self-healing after fracture can be obtained. For example, when the secondary battery is repeatedly used for charging and discharging, the electrode may expand and the binder may break, but even if the binder is broken, the binder will still repair itself to prevent the electrode from decomposing, thereby preventing battery performance from deteriorating.
<其他> 本揭示內容中,可舉出如以下之態樣。 [1] 下述式(1)所示之化合物。 <Other> In this disclosure, the following aspects can be mentioned. [1] A compound represented by the following formula (1).
式(1)中,R 1、R 2、R 3及R 4係各自獨立表示氫原子、碳原子數1~50之聚合性官能基或碳原子數1~50之烷基。該烷基亦可具有雜原子。該烷基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代。該烷基中之氫原子之一部分亦可被鹵素原子所取代。n1表示1~10之整數。R 1、R 2、R 3及R 4之至少一個表示碳原子數1~50之聚合性官能基。但,去除R 1、R 2、R 3及R 4之任意兩個連結而成為環構造之化合物。 In formula (1), R 1 , R 2 , R 3 and R 4 each independently represent a hydrogen atom, a polymerizable functional group with 1 to 50 carbon atoms, or an alkyl group with 1 to 50 carbon atoms. The alkyl group may also have heteroatoms. Part of the methylene group in the alkyl group may be substituted by an ether bond, thioether bond, ester bond, amide bond, imide bond or carbonyl. Part of the hydrogen atoms in the alkyl group may be substituted by halogen atoms. n1 represents an integer from 1 to 10. At least one of R 1 , R 2 , R 3 and R 4 represents a polymerizable functional group having 1 to 50 carbon atoms. However, any two of R 1 , R 2 , R 3 and R 4 are removed to form a compound having a ring structure.
[2] 如[1]記載之化合物,其中碳原子數1~50之聚合性官能基為選自由乙烯基、烯丙基、丙烯醯基、甲基丙烯醯基、羥基、異氰酸酯基、胺基、醯胺基、環氧基、環氧丙烷基、環硫化物基、羧基、雜芳基、巰基、包含羧酸酐構造之基及包含環狀醯亞胺構造之基所成群之作用基與烴基經結合之基,該烴基中之亞甲基之一部分亦可被醚鍵、硫醚鍵、酯鍵、醯胺鍵、醯亞胺鍵或羰基所取代,該聚合性官能基中之氫原子之一部分亦可被鹵素原子所取代。[2] The compound as described in [1], wherein the polymerizable functional group having 1 to 50 carbon atoms is selected from the group consisting of vinyl, allyl, acryl, methacryl, hydroxyl, isocyanate, and amino , amide group, epoxy group, epoxypropylene group, episulfide group, carboxyl group, heteroaryl group, mercapto group, group containing carboxylic acid anhydride structure and group containing cyclic imide structure. A group in which a hydrocarbon group is bonded, a part of the methylene group in the hydrocarbon group may be substituted by an ether bond, a thioether bond, an ester bond, an amide bond, an imide bond or a carbonyl group, and the hydrogen atom in the polymerizable functional group A part may also be substituted by a halogen atom.
[3] 如[1]或[2]記載之化合物,其中碳原子數1~50之聚合性官能基為下述式(L-1)所示之基。[3] The compound described in [1] or [2], wherein the polymerizable functional group having 1 to 50 carbon atoms is a group represented by the following formula (L-1).
式(L-1)中,L 1及L 2係各自獨立表示碳原子數1~5之烷二基。n表示0~5之整數。n表示2以上之整數時,複數之L 1可為相同之基,亦可為相異之基。*表示與式(1)中之氮原子之鍵結位置。 In the formula (L-1), L 1 and L 2 each independently represent an alkanediyl group having 1 to 5 carbon atoms. n represents an integer from 0 to 5. When n represents an integer of 2 or more, L 1 of the plural number may be the same base or different bases. * represents the bonding position with the nitrogen atom in the formula (1).
[4] 一種硬化性組成物,其係包含如[1]~[3]中任一項記載之化合物。[4] A curable composition comprising the compound described in any one of [1] to [3].
[5] 如[4]記載之硬化性組成物,其中更包含選自由硬化劑及聚合起始劑所成群之至少1種。[5] The curable composition according to [4], further comprising at least one member selected from the group consisting of a curing agent and a polymerization initiator.
[6] 如[5]記載之硬化性組成物,其中硬化劑為選自由胺化合物、醯胺化合物、酸酐化合物、硫醇化合物、酚化合物、咪唑化合物及潛伏性硬化劑所成群之至少1種。[6] The curable composition as described in [5], wherein the curing agent is at least 1 selected from the group consisting of amine compounds, amide compounds, acid anhydride compounds, thiol compounds, phenol compounds, imidazole compounds and latent curing agents. kind.
[7] 如[5]或[6]記載之硬化性組成物,其中聚合起始劑為陽離子聚合起始劑或自由基聚合起始劑。[7] The curable composition according to [5] or [6], wherein the polymerization initiator is a cationic polymerization initiator or a radical polymerization initiator.
[8] 如[4]~[7]中任一項記載之硬化性組成物,其係自我修復材料、表面塗覆劑、塗料、接著劑或電池用材料。[8] The curable composition described in any one of [4] to [7], which is a self-healing material, surface coating agent, paint, adhesive, or battery material.
[9] 一種硬化物,其係使如[4]~[8]中任一項記載之硬化性組成物硬化而成者。 [實施例] [9] A cured product obtained by curing the curable composition described in any one of [4] to [8]. [Example]
以下,例舉實施例來具體地說明本發明,但本發明並非係受到該等所限定者。Hereinafter, although an Example is given and this invention is demonstrated concretely, this invention is not limited to these.
[實施例1]化合物No.2之製造 在500mL之圓底燒瓶中添加二甲基甲醯胺200g、2-(tert-丁基胺基)乙基丙烯酸酯50.0g及乙酸鈉27.0g,進行攪拌混合後,在室溫下滴下使二氯化二硫19.7g溶解於二甲基甲醯胺59.2g者,攪拌2小時使其反應。反應結束後,添加乙酸丁酯及水來進行油水分離。進行水洗,減壓餾除溶劑,在-37℃下靜置48小時,過濾分離已析出之固體而取得無色結晶43.7g。對於取得之無色結晶,利用 1H-NMR及元素分析所得之分析結果,確認為目的化合物之化合物No.2。取得之化合物之收率為77%。以下展示分析結果。 [Example 1] Production of Compound No. 2 Add 200 g of dimethylformamide, 50.0 g of 2-(tert-butylamino) ethyl acrylate, and 27.0 g of sodium acetate to a 500 mL round-bottomed flask. After stirring and mixing, 19.7 g of disulfur dichloride was dissolved in 59.2 g of dimethylformamide dropwise at room temperature, and stirred for 2 hours to react. After completion of the reaction, butyl acetate and water were added to perform oil-water separation. After washing with water, the solvent was distilled off under reduced pressure, and it was left to stand at -37°C for 48 hours, and the precipitated solid was separated by filtration to obtain 43.7 g of colorless crystals. The obtained colorless crystals were confirmed to be Compound No. 2 of the target compound from the analysis results obtained by 1 H-NMR and elemental analysis. The yield of the obtained compound was 77%. The analysis results are shown below.
(1) 1H-NMR(400MHz,CDCl3) δ=1.24(s, 18H)、1.96(s, 6H)、3.12-3.28(br, 4H)、4.36 (t, 4H)、5.55-5.60(m, 2H)、6.11-6.15(m, 2H) (1) 1 H-NMR(400MHz,CDCl3) δ=1.24(s, 18H), 1.96(s, 6H), 3.12-3.28(br, 4H), 4.36 (t, 4H), 5.55-5.60(m, 2H), 6.11-6.15(m, 2H)
(2)元素分析 C:54.5質量%(理論值:55.5質量%)、H:8.2質量% (理論值:8.4質量%)、N:6.6質量%(理論值:6.5質量%)、S:14.5質量%(理論值:14.8質量%) (2) Elemental analysis C: 54.5% by mass (theoretical value: 55.5% by mass), H: 8.2% by mass (theoretical value: 8.4% by mass), N: 6.6% by mass (theoretical value: 6.5% by mass), S: 14.5% by mass (theoretical value : 14.8% by mass)
[實施例2]化合物No.12之製造 在300mL之圓底燒瓶中添加實施例1所製造之化合物No.2 15.0g、水21.3g、乙醇61.5g及35%氫氧化鉀水溶液14.5g,攪拌1小時混合後,將圓底燒瓶內之混合溶液全部添加至甲苯400mL中,再添加水200mL,並重複水洗直到水層成為中性為止。確認到水層變成中性後,減壓餾除溶劑,並直接在室溫下靜置。24小時後,過濾分離已析出之結晶,進行真空乾燥而取得白色粉末之結晶6.88g。對於取得之白色粉末,利用 1H-NMR及元素分析所得之分析結果,確認為目的化合物之化合物No.12。取得之化合物之收率為67%。以下展示分析結果。 [Example 2] Production of Compound No. 12 Add 15.0 g of Compound No. 2 produced in Example 1, 21.3 g of water, 61.5 g of ethanol and 14.5 g of 35% aqueous potassium hydroxide solution to a 300 mL round bottom flask, and stir After mixing for 1 hour, all the mixed solution in the round bottom flask was added to 400 mL of toluene, and then 200 mL of water was added, and water washing was repeated until the water layer became neutral. After confirming that the aqueous layer had become neutral, the solvent was distilled off under reduced pressure, and the mixture was left standing at room temperature as it was. After 24 hours, the precipitated crystals were separated by filtration and vacuum-dried to obtain 6.88 g of white powder crystals. The obtained white powder was confirmed to be Compound No. 12 of the target compound by 1 H-NMR and elemental analysis. The yield of the obtained compound was 67%. The analysis results are shown below.
(1) 1H-NMR(400MHz,CDCl3) δ=1.26(s, 18H)、2.82-2.90(m, 2H)、3.02-3.14 (m, 4H)、3.81-3.94(m, 4H) (1) 1 H-NMR (400MHz, CDCl3) δ=1.26(s, 18H), 2.82-2.90(m, 2H), 3.02-3.14 (m, 4H), 3.81-3.94(m, 4H)
(2)元素分析 C:48.5質量%(理論值:48.6質量%)、H:9.6質量% (理論值:9.5質量%)、N:9.2質量%(理論值:9.5質量%)、S:21.2質量%(理論值:21.6質量%) (2) Elemental analysis C: 48.5% by mass (theoretical value: 48.6% by mass), H: 9.6% by mass (theoretical value: 9.5% by mass), N: 9.2% by mass (theoretical value: 9.5% by mass), S: 21.2% by mass (theoretical value : 21.6% by mass)
[實施例3]化合物No.6(環氧樹脂)之製造 在100mL之圓底燒瓶中添加實施例2所製造之化合物No.12 5.00g、表氯醇49.88g及氯化四甲基銨0.185g,升溫至70℃進行攪拌而使化合物No.12溶解後,徐緩添加48%氫氧化鈉水溶液3.51g並攪拌3小時。攪拌後,減壓餾除溶劑,添加甲苯100mL,再添加水100mL來進行油水分離,重複水洗直到水層成為中性為止。確認到水層變成中性後,減壓餾除甲苯,過濾分離而取得6.54g之黏稠性液體。對於取得之液體,使用下述方法所算出之環氧當量為235,確認為以化合物No.6為主成分之環氧樹脂。取得之環氧樹脂之收率為94.9%。以下展示分析結果。 [Example 3] Production of Compound No.6 (epoxy resin) Add 5.00 g of compound No.12 produced in Example 2, 49.88 g of epichlorohydrin, and 0.185 g of tetramethylammonium chloride to a 100 mL round-bottomed flask, heat up to 70°C and stir to dissolve compound No.12 , 3.51 g of 48% aqueous sodium hydroxide solution was gradually added and stirred for 3 hours. After stirring, the solvent was distilled off under reduced pressure, 100 mL of toluene was added, and 100 mL of water was added for oil-water separation, and water washing was repeated until the water layer became neutral. After confirming that the water layer became neutral, toluene was distilled off under reduced pressure, and 6.54 g of viscous liquid was obtained by filtering and separating. The obtained liquid had an epoxy equivalent of 235 calculated by the following method, and it was confirmed that it was an epoxy resin mainly composed of Compound No. 6. The yield of the obtained epoxy resin was 94.9%. The analysis results are shown below.
(1)環氧當量 依據JIS K7237,藉由利用過氯酸之微分滴定來算出胺當量,依據JIS K7236,藉由利用過氯酸之微分滴定,來算出環氧當量及胺當量之總量,環氧當量係算出作為總量與胺當量之差。 (1) epoxy equivalent According to JIS K7237, the amine equivalent is calculated by using the differential titration of perchloric acid. According to JIS K7236, the total amount of epoxy equivalent and amine equivalent is calculated by using the differential titration of perchloric acid. The epoxy equivalent is calculated as The difference between the total amount and the amine equivalent.
(2)元素分析 括弧內之數值為化合物No.6(環氧樹脂)之理論值 C:52.5質量%(52.9質量%)、H:8.9質量%(8.9質量%)、N:6.9質量%(6.9質量%)、S:15.5質量%(15.7質量%) (2) Elemental analysis The value in brackets is the theoretical value of compound No.6 (epoxy resin) C: 52.5% by mass (52.9% by mass), H: 8.9% by mass (8.9% by mass), N: 6.9% by mass (6.9% by mass), S: 15.5% by mass (15.7% by mass)
[實施例4] 混合作為本發明化合物之實施例1所製造之化合物No.2 10質量份、作為其他單體之甲基丙烯酸己基90質量份、作為聚合起始劑之2,2-二甲氧基苯乙酮5.0質量份及2,2’-偶氮雙(2,4-二甲基戊腈)1.0質量份而調製出實施例4之硬化性組成物。將該硬化性組成物塗佈於玻璃板上後,放上覆蓋薄膜,以3mW/cm 2之輸出來照射高壓水銀燈660秒鐘後,在50℃之烤箱內靜置12小時使其完全硬化而取得塗膜試料。對於取得之塗膜試料,以4B之鉛筆來賦予擦傷痕跡後,在120℃之烤箱內靜置並以顯微鏡經時地觀察擦傷痕跡,在2小時處確認到擦傷痕跡消失。 [Example 4] Mix 10 parts by mass of Compound No. 2 produced in Example 1 as the compound of the present invention, 90 parts by mass of hexyl methacrylate as another monomer, and 2,2-dimethyl as a polymerization initiator 5.0 parts by mass of oxyacetophenone and 1.0 parts by mass of 2,2'-azobis(2,4-dimethylvaleronitrile) were used to prepare the curable composition of Example 4. After coating this curable composition on a glass plate, put a cover film on it, irradiate a high-pressure mercury lamp with an output of 3mW/ cm2 for 660 seconds, and then let it stand in an oven at 50°C for 12 hours to completely harden it. Obtain a coating sample. The obtained coating film sample was given scratch marks with a 4B pencil, left to stand in an oven at 120°C, and the scratch marks were observed with a microscope over time, and it was confirmed that the scratch marks disappeared after 2 hours.
[比較例1] 除了取代化合物No.2而改用乙氧基化雙酚A甲基丙烯酸酯(新中村化學工業公司製NK酯BPE-200)以外,其他係與實施例4相同之操作順序來調製出比較例1之硬化性組成物而取得塗膜試料。對於取得之塗膜試料,以4B鉛筆來賦予擦傷痕跡後,在120℃之烤箱內靜置並以顯微鏡經時地觀察擦傷痕跡,即使經過3時間仍確認到擦傷痕跡殘留。 [Comparative example 1] Except for replacing compound No.2 with ethoxylated bisphenol A methacrylate (NK Ester BPE-200 manufactured by Shin Nakamura Chemical Industry Co., Ltd.), the other operations were the same as in Example 4 to prepare a comparative example. 1 curable composition to obtain coating samples. The obtained coating film samples were scratched with a 4B pencil, left to stand in an oven at 120° C., and scratches were observed with a microscope over time. Even after 3 hours, scratches remained.
[實施例5、實施例6、比較例2及比較例3] 使用以實施例3取得之化合物No.6為主成分之環氧樹脂、作為其他單體之下述化合物a及化合物b,及作為硬化劑之下述化合物c,以下述表1所示之摻合來進行混合而調製出硬化性組成物。將取得之硬化性組成物塗佈於玻璃板上後,放上覆蓋薄膜,在120℃之烤箱內靜置42小時使其硬化而得到塗膜試料。對於取得之塗膜試料,以2H鉛筆來賦予擦傷痕跡後,在60℃之烤箱內靜置,以倍率10倍之顯微鏡來觀察經過16小時後、經過24小時後及經過40小時後之擦傷痕跡。在使用顯微鏡之觀察下,將擦傷痕跡消失之情況評價為「○」,將在目視下擦傷痕跡消失,但使用顯微鏡之觀察下會確認到擦傷痕之情況評價為「△」,將能以目視確認到擦傷痕跡之情況評價為「×」。將評價結果展示於表1。 [Example 5, Example 6, Comparative Example 2 and Comparative Example 3] Using the epoxy resin whose main component is Compound No. 6 obtained in Example 3, the following compound a and compound b as other monomers, and the following compound c as a hardening agent, the mixture shown in the following Table 1 was used. Mix together to prepare a curable composition. After coating the obtained curable composition on a glass plate, put a cover film on it, and let it stand in an oven at 120° C. for 42 hours to harden to obtain a coating film sample. For the obtained coating film sample, use a 2H pencil to give scratch marks, then let it stand in an oven at 60°C, and observe the scratch marks after 16 hours, 24 hours, and 40 hours with a microscope with a magnification of 10 times . Under observation using a microscope, the case where scratches disappeared was evaluated as "○", and the case where scratches disappeared visually, but scratches were confirmed under microscope observation was evaluated as "△", and those that could be observed visually The case where scratch marks were confirmed was evaluated as "x". The evaluation results are shown in Table 1.
化合物a(其他單體):二環戊二烯二甲醇二環氧丙基醚 化合物b(其他單體):2,2-二甲基-1,3-丙二醇二環氧丙基醚 化合物c(硬化劑):2-乙基-4-甲基咪唑 Compound a (other monomers): Dicyclopentadiene Dimethanol Diglycidyl Ether Compound b (other monomers): 2,2-dimethyl-1,3-propanediol diglycidyl ether Compound c (hardener): 2-ethyl-4-methylimidazole
由以上之結果,可得知根據本發明,藉由使用讓式(1)所示之化合物或式(2)所示之化合物與表鹵醇類反應而得之環氧樹脂,而可取得具有優異自我修復力之材料。From the above results, it can be known that according to the present invention, the epoxy resin having the Materials with excellent self-healing ability.
Claims (9)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021-074798 | 2021-04-27 | ||
| JP2021074798 | 2021-04-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW202311205A true TW202311205A (en) | 2023-03-16 |
Family
ID=83847104
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW111115598A TW202311205A (en) | 2021-04-27 | 2022-04-25 | Compound, curable composition, and cured product |
Country Status (5)
| Country | Link |
|---|---|
| JP (1) | JPWO2022230745A1 (en) |
| KR (1) | KR20240001162A (en) |
| CN (1) | CN117203187A (en) |
| TW (1) | TW202311205A (en) |
| WO (1) | WO2022230745A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPWO2023153444A1 (en) * | 2022-02-14 | 2023-08-17 | ||
| JPWO2024143072A1 (en) * | 2022-12-28 | 2024-07-04 | ||
| WO2024203514A1 (en) * | 2023-03-30 | 2024-10-03 | 株式会社Adeka | Urethane prepolymer composition, urethane resin composition, and cured product of urethane resin composition |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS56125326A (en) * | 1980-03-07 | 1981-10-01 | Asahi Kagaku Kogyo Kk | Preparation of chlorinated phenoxytoluenes in high selectivity |
| WO2007069765A1 (en) | 2005-12-16 | 2007-06-21 | Japan Advanced Institute Of Science And Technology | Self-repairing material |
| US10106628B2 (en) | 2012-04-27 | 2018-10-23 | Osaka University | Gel with self-restorability and shape-memory property and process for producing same |
| JP6566937B2 (en) | 2013-06-13 | 2019-08-28 | オートノミック マテリアルズ、インコーポレイテッド | Self-healing polymer material with unsaturated polyester |
| JP6300926B2 (en) | 2014-07-08 | 2018-03-28 | 国立大学法人大阪大学 | Self-healing polymer material and method for producing the same |
| JP6813147B2 (en) * | 2016-05-09 | 2021-01-13 | 国立大学法人東京工業大学 | Dynamic covalent compound and its recombination method |
| JP6746129B2 (en) | 2016-06-08 | 2020-08-26 | 国立大学法人 鹿児島大学 | Self-healing material |
| US11667609B2 (en) * | 2019-02-28 | 2023-06-06 | Adeka Corporation | Compound, composition containing said compound, self-healing material, surface coating agent, paint, adhesive, material for battery and cured product |
-
2022
- 2022-04-21 WO PCT/JP2022/018378 patent/WO2022230745A1/en not_active Ceased
- 2022-04-21 KR KR1020237038261A patent/KR20240001162A/en active Pending
- 2022-04-21 JP JP2023517474A patent/JPWO2022230745A1/ja active Pending
- 2022-04-21 CN CN202280031016.1A patent/CN117203187A/en active Pending
- 2022-04-25 TW TW111115598A patent/TW202311205A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN117203187A (en) | 2023-12-08 |
| WO2022230745A1 (en) | 2022-11-03 |
| KR20240001162A (en) | 2024-01-03 |
| JPWO2022230745A1 (en) | 2022-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113544120B (en) | Novel compound, composition containing same, self-repairing material, surface coating agent, paint, adhesive, battery material, and cured product | |
| TW202311205A (en) | Compound, curable composition, and cured product | |
| US8450498B2 (en) | Ionic liquid epoxy resin monomers | |
| CN105934459B (en) | Curable resin excellent in flexibility after curing, (meth)acrylated curable resin, and liquid crystal sealing compound composition | |
| JP7397157B2 (en) | Thiol compounds, their synthesis methods and uses of the thiol compounds | |
| JP7186170B2 (en) | Solvent-free ionic liquid epoxy resin | |
| JP7236041B2 (en) | Curing agent and its use | |
| JP7199917B2 (en) | Thiol compound, its synthesis method and use of said thiol compound | |
| JP7106426B2 (en) | Thiol compound, its synthesis method and use of said thiol compound | |
| JP7106425B2 (en) | Thiol compound, its synthesis method and use of said thiol compound | |
| JP7577482B2 (en) | Compound, composition containing said compound, and cured product | |
| JP2022037478A (en) | Compounds, compositions and cured products containing the compounds | |
| CN110914329B (en) | Composition comprising a metal oxide and a metal oxide | |
| JP7106429B2 (en) | Thiol compound, its synthesis method and use of said thiol compound | |
| KR20250127045A (en) | Curable resin composition, adhesive, encapsulant, cured product, semiconductor device, and electronic device | |
| CN115003709B (en) | Compound, method for producing compound, and curable composition | |
| TW202212337A (en) | Composition, cured product, and method for producing the cured product | |
| JP2016030822A (en) | REINFORCED FIBER RESIN COMPOSITE AND METHOD FOR PRODUCING REINFORCED STRUCTURE USING THE SAME | |
| TW202344532A (en) | Adhesive composition, cured product, laminate, laminate production method, and adhesiveness imparting agent | |
| CN119183463A (en) | Curing agent and its use | |
| JP2017210582A (en) | Epoxy compound, epoxy compound-containing composition, and cured product thereof | |
| JP4560672B2 (en) | Curable resin composition |